0000037785 2020 Q3 FALSE--12-31 us-gaap:OtherAssetsNoncurrent us-gaap:AccruedLiabilitiesCurrent us-gaap:OtherLiabilitiesNoncurrent 0000037785 2020-01-01 2020-09-30 xbrli:shares 0000037785 2020-09-30 iso4217:USD 0000037785 2020-07-01 2020-09-30 0000037785 2019-07-01 2019-09-30 0000037785 2019-01-01 2019-09-30 iso4217:USD xbrli:shares 0000037785 2019-12-31 0000037785 2018-12-31 0000037785 2019-09-30 0000037785 2020-06-30 0000037785 2020-03-31 0000037785 us-gaap:CommonStockMember 2019-12-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000037785 us-gaap:RetainedEarningsMember 2019-12-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000037785 us-gaap:TreasuryStockMember 2019-12-31 0000037785 us-gaap:NoncontrollingInterestMember 2019-12-31 0000037785 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000037785 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000037785 2020-01-01 2020-03-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000037785 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000037785 us-gaap:CommonStockMember 2020-03-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000037785 us-gaap:RetainedEarningsMember 2020-03-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000037785 us-gaap:TreasuryStockMember 2020-03-31 0000037785 us-gaap:NoncontrollingInterestMember 2020-03-31 0000037785 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000037785 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0000037785 2020-04-01 2020-06-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000037785 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000037785 us-gaap:CommonStockMember 2020-06-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000037785 us-gaap:RetainedEarningsMember 2020-06-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000037785 us-gaap:TreasuryStockMember 2020-06-30 0000037785 us-gaap:NoncontrollingInterestMember 2020-06-30 0000037785 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000037785 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000037785 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:CommonStockMember 2020-09-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000037785 us-gaap:RetainedEarningsMember 2020-09-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000037785 us-gaap:TreasuryStockMember 2020-09-30 0000037785 us-gaap:NoncontrollingInterestMember 2020-09-30 xbrli:pure 0000037785 fmc:PTBinaGunaKimiaMember 2020-07-31 0000037785 2020-07-01 2020-07-31 0000037785 fmc:PTBinaGunaKimiaMember 2020-08-01 0000037785 2019-03-31 0000037785 2019-06-30 0000037785 us-gaap:CommonStockMember 2018-12-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000037785 us-gaap:RetainedEarningsMember 2018-12-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000037785 us-gaap:TreasuryStockMember 2018-12-31 0000037785 us-gaap:NoncontrollingInterestMember 2018-12-31 0000037785 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000037785 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0000037785 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000037785 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000037785 2019-01-01 2019-03-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000037785 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000037785 us-gaap:CommonStockMember 2019-03-31 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000037785 us-gaap:RetainedEarningsMember 2019-03-31 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000037785 us-gaap:TreasuryStockMember 2019-03-31 0000037785 us-gaap:NoncontrollingInterestMember 2019-03-31 0000037785 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000037785 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0000037785 2019-04-01 2019-06-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000037785 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000037785 us-gaap:CommonStockMember 2019-06-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000037785 us-gaap:RetainedEarningsMember 2019-06-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000037785 us-gaap:TreasuryStockMember 2019-06-30 0000037785 us-gaap:NoncontrollingInterestMember 2019-06-30 0000037785 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000037785 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000037785 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:CommonStockMember 2019-09-30 0000037785 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000037785 us-gaap:RetainedEarningsMember 2019-09-30 0000037785 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000037785 us-gaap:TreasuryStockMember 2019-09-30 0000037785 us-gaap:NoncontrollingInterestMember 2019-09-30 fmc:product 0000037785 srt:NorthAmericaMember 2020-07-01 2020-09-30 0000037785 srt:NorthAmericaMember 2019-07-01 2019-09-30 0000037785 srt:NorthAmericaMember 2020-01-01 2020-09-30 0000037785 srt:NorthAmericaMember 2019-01-01 2019-09-30 0000037785 srt:LatinAmericaMember 2020-07-01 2020-09-30 0000037785 srt:LatinAmericaMember 2019-07-01 2019-09-30 0000037785 srt:LatinAmericaMember 2020-01-01 2020-09-30 0000037785 srt:LatinAmericaMember 2019-01-01 2019-09-30 0000037785 us-gaap:EMEAMember 2020-07-01 2020-09-30 0000037785 us-gaap:EMEAMember 2019-07-01 2019-09-30 0000037785 us-gaap:EMEAMember 2020-01-01 2020-09-30 0000037785 us-gaap:EMEAMember 2019-01-01 2019-09-30 0000037785 srt:AsiaMember 2020-07-01 2020-09-30 0000037785 srt:AsiaMember 2019-07-01 2019-09-30 0000037785 srt:AsiaMember 2020-01-01 2020-09-30 0000037785 srt:AsiaMember 2019-01-01 2019-09-30 0000037785 fmc:InsecticidesMember 2020-07-01 2020-09-30 0000037785 fmc:InsecticidesMember 2019-07-01 2019-09-30 0000037785 fmc:InsecticidesMember 2020-01-01 2020-09-30 0000037785 fmc:InsecticidesMember 2019-01-01 2019-09-30 0000037785 fmc:HerbicidesMember 2020-07-01 2020-09-30 0000037785 fmc:HerbicidesMember 2019-07-01 2019-09-30 0000037785 fmc:HerbicidesMember 2020-01-01 2020-09-30 0000037785 fmc:HerbicidesMember 2019-01-01 2019-09-30 0000037785 fmc:FungicidesMember 2020-07-01 2020-09-30 0000037785 fmc:FungicidesMember 2019-07-01 2019-09-30 0000037785 fmc:FungicidesMember 2020-01-01 2020-09-30 0000037785 fmc:FungicidesMember 2019-01-01 2019-09-30 0000037785 fmc:OtherAgriculturalSolutionsMember 2020-07-01 2020-09-30 0000037785 fmc:OtherAgriculturalSolutionsMember 2019-07-01 2019-09-30 0000037785 fmc:OtherAgriculturalSolutionsMember 2020-01-01 2020-09-30 0000037785 fmc:OtherAgriculturalSolutionsMember 2019-01-01 2019-09-30 0000037785 srt:MinimumMember 2020-01-01 2020-09-30 0000037785 srt:MaximumMember 2020-01-01 2020-09-30 0000037785 srt:MinimumMember 2020-09-30 0000037785 srt:MaximumMember 2020-09-30 0000037785 us-gaap:RealEstateMember srt:MinimumMember 2020-09-30 0000037785 srt:MaximumMember us-gaap:RealEstateMember 2020-09-30 0000037785 fmc:NonRealEstatePropertiesMember srt:MinimumMember 2020-09-30 0000037785 srt:MaximumMember fmc:NonRealEstatePropertiesMember 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember 2017-11-01 2017-11-01 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember 2020-07-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember 2020-01-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember 2019-07-01 2019-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember 2019-01-01 2019-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember fmc:LegalandProfessionalFeesMember 2020-07-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember fmc:LegalandProfessionalFeesMember 2019-07-01 2019-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember fmc:LegalandProfessionalFeesMember 2020-01-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember fmc:LegalandProfessionalFeesMember 2019-01-01 2019-09-30 0000037785 fmc:DuPontCropRestructuringMember 2020-07-01 2020-09-30 0000037785 fmc:DuPontCropRestructuringMember 2019-07-01 2019-09-30 0000037785 fmc:DuPontCropRestructuringMember 2020-01-01 2020-09-30 0000037785 fmc:DuPontCropRestructuringMember 2019-01-01 2019-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember srt:MinimumMember 2020-01-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember srt:MaximumMember 2020-01-01 2020-09-30 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember srt:ScenarioForecastMember srt:MinimumMember 2021-01-01 2021-12-31 0000037785 fmc:E.I.duPontdeNemoursandCompanyMember srt:ScenarioForecastMember srt:MaximumMember 2021-01-01 2021-12-31 0000037785 us-gaap:CustomerRelationshipsMember 2020-09-30 0000037785 us-gaap:CustomerRelationshipsMember 2019-12-31 0000037785 us-gaap:PatentsMember 2020-09-30 0000037785 us-gaap:PatentsMember 2019-12-31 0000037785 fmc:BrandsMember 2020-09-30 0000037785 fmc:BrandsMember 2019-12-31 0000037785 us-gaap:DevelopedTechnologyRightsMember 2020-09-30 0000037785 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000037785 us-gaap:OtherIntangibleAssetsMember 2020-09-30 0000037785 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000037785 fmc:CropProtectionBrandsMember 2020-09-30 0000037785 fmc:CropProtectionBrandsMember 2019-12-31 0000037785 fmc:BrandsMember 2020-09-30 0000037785 fmc:BrandsMember 2019-12-31 0000037785 2019-01-01 2019-12-31 0000037785 fmc:DuPontCropRestructuringMember 2020-07-01 2020-09-30 0000037785 fmc:OtherRestructuringActivitiesMember 2020-07-01 2020-09-30 0000037785 fmc:DuPontCropRestructuringMember 2019-07-01 2019-09-30 0000037785 fmc:OtherRestructuringActivitiesMember 2019-07-01 2019-09-30 0000037785 fmc:DuPontCropRestructuringMember 2020-01-01 2020-09-30 0000037785 fmc:OtherRestructuringActivitiesMember 2020-01-01 2020-09-30 0000037785 fmc:DuPontCropRestructuringMember 2019-01-01 2019-09-30 0000037785 fmc:OtherRestructuringActivitiesMember 2019-01-01 2019-09-30 0000037785 fmc:DuPontCropRestructuringMember 2019-12-31 0000037785 fmc:DuPontCropRestructuringMember 2020-09-30 0000037785 fmc:OtherRestructuringActivitiesMember 2019-12-31 0000037785 fmc:OtherRestructuringActivitiesMember 2020-09-30 0000037785 fmc:ShorttermForeignDebtMember 2020-09-30 0000037785 fmc:ShorttermForeignDebtMember 2019-12-31 0000037785 us-gaap:CommercialPaperMember 2020-09-30 0000037785 us-gaap:CommercialPaperMember 2019-12-31 0000037785 fmc:PollutionControlAndIndustrialRevenueBondsMember 2020-09-30 0000037785 fmc:PollutionControlAndIndustrialRevenueBondsMember 2020-03-31 0000037785 fmc:PollutionControlAndIndustrialRevenueBondsMember srt:MinimumMember 2020-09-30 0000037785 fmc:PollutionControlAndIndustrialRevenueBondsMember srt:MaximumMember 2020-09-30 0000037785 fmc:PollutionControlAndIndustrialRevenueBondsMember 2019-12-31 0000037785 us-gaap:SeniorNotesMember 2020-09-30 0000037785 us-gaap:SeniorNotesMember 2020-03-31 0000037785 us-gaap:SeniorNotesMember srt:MinimumMember 2020-09-30 0000037785 us-gaap:SeniorNotesMember srt:MaximumMember 2020-09-30 0000037785 us-gaap:SeniorNotesMember 2019-12-31 0000037785 fmc:TermLoanFacility2017Member 2020-09-30 0000037785 fmc:TermLoanFacility2017Member 2019-12-31 0000037785 fmc:RevolvingCreditAgreementMember 2020-09-30 0000037785 fmc:RevolvingCreditAgreementMember 2019-12-31 0000037785 fmc:ForeignDebtMember srt:MinimumMember 2020-09-30 0000037785 srt:MaximumMember fmc:ForeignDebtMember 2020-09-30 0000037785 fmc:ForeignDebtMember 2020-09-30 0000037785 fmc:ForeignDebtMember 2019-12-31 0000037785 fmc:RevolvingCreditAgreementMember us-gaap:SubsequentEventMember 2021-01-01 2021-06-30 0000037785 us-gaap:SubsequentEventMember fmc:TermLoanAgreementMember 2021-01-01 2021-09-30 0000037785 2020-04-22 0000037785 srt:ScenarioForecastMember 2021-01-01 2021-03-31 0000037785 srt:ScenarioForecastMember 2021-07-01 2021-09-30 0000037785 srt:ScenarioForecastMember 2022-07-01 2022-09-30 0000037785 fmc:LiventMember 2019-03-01 0000037785 fmc:FMCLithiumMember 2020-01-01 2020-09-30 0000037785 fmc:FMCLithiumMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-07-01 2020-09-30 0000037785 fmc:FMCLithiumMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-07-01 2019-09-30 0000037785 fmc:FMCLithiumMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-01-01 2020-09-30 0000037785 fmc:FMCLithiumMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-01-01 2019-09-30 0000037785 fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember 2020-07-01 2020-09-30 0000037785 fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember 2019-07-01 2019-09-30 0000037785 fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember 2020-01-01 2020-09-30 0000037785 fmc:DiscontinuedworkerscompensationproductliabilityandotherpostretirementbenefitsMember 2019-01-01 2019-09-30 0000037785 fmc:DiscontinuedEnvironmentalLiabilitiesMember 2020-07-01 2020-09-30 0000037785 fmc:DiscontinuedEnvironmentalLiabilitiesMember 2019-07-01 2019-09-30 0000037785 fmc:DiscontinuedEnvironmentalLiabilitiesMember 2020-01-01 2020-09-30 0000037785 fmc:DiscontinuedEnvironmentalLiabilitiesMember 2019-01-01 2019-09-30 0000037785 fmc:DiscontinuedLegalExpensesMember 2020-07-01 2020-09-30 0000037785 fmc:DiscontinuedLegalExpensesMember 2019-07-01 2019-09-30 0000037785 fmc:DiscontinuedLegalExpensesMember 2020-01-01 2020-09-30 0000037785 fmc:DiscontinuedLegalExpensesMember 2019-01-01 2019-09-30 0000037785 fmc:FMCLithiumMember 2020-07-01 2020-09-30 0000037785 fmc:FMCLithiumMember 2019-07-01 2019-09-30 0000037785 fmc:FMCLithiumMember 2019-01-01 2019-09-30 fmc:parcelOfLand 0000037785 fmc:NewarkEnvironmentalSiteMember 2019-01-01 2019-06-30 0000037785 fmc:GrossMember 2019-12-31 0000037785 fmc:RecoveriesMember 2019-12-31 0000037785 fmc:NetMember 2019-12-31 0000037785 fmc:GrossMember 2020-01-01 2020-09-30 0000037785 fmc:RecoveriesMember 2020-01-01 2020-09-30 0000037785 fmc:NetMember 2020-01-01 2020-09-30 0000037785 fmc:GrossMember 2020-09-30 0000037785 fmc:RecoveriesMember 2020-09-30 0000037785 fmc:NetMember 2020-09-30 0000037785 fmc:OtherAssetsIncludingLongtermReceivablesNetMember 2019-12-31 0000037785 fmc:OtherAssetsIncludingLongtermReceivablesNetMember 2020-01-01 2020-09-30 0000037785 fmc:OtherAssetsIncludingLongtermReceivablesNetMember 2020-09-30 0000037785 2020-01-01 2020-06-30 0000037785 us-gaap:OtherLiabilitiesMember 2020-07-01 2020-09-30 0000037785 us-gaap:OtherLiabilitiesMember 2019-07-01 2019-09-30 0000037785 us-gaap:OtherLiabilitiesMember 2020-01-01 2020-09-30 0000037785 us-gaap:OtherLiabilitiesMember 2019-01-01 2019-09-30 0000037785 us-gaap:OtherAssetsMember 2020-07-01 2020-09-30 0000037785 us-gaap:OtherAssetsMember 2019-07-01 2019-09-30 0000037785 us-gaap:OtherAssetsMember 2020-01-01 2020-09-30 0000037785 us-gaap:OtherAssetsMember 2019-01-01 2019-09-30 0000037785 us-gaap:SegmentContinuingOperationsMember 2020-07-01 2020-09-30 0000037785 us-gaap:SegmentContinuingOperationsMember 2019-07-01 2019-09-30 0000037785 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-09-30 0000037785 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember 2020-07-01 2020-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember 2019-07-01 2019-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-09-30 0000037785 fmc:AirDepositionArea2Member 2020-09-30 2020-09-30 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-30 0000037785 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000037785 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ForeignExchangeContractMember 2019-07-01 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ForeignExchangeContractMember 2019-01-01 2019-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-07-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-07-01 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetTransitionAssetObligationMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000037785 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000037785 us-gaap:SubsequentEventMember 2020-10-15 2020-10-15 0000037785 us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000037785 us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000037785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000037785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-30 0000037785 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000037785 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000037785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000037785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-30 0000037785 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-20 2019-09-20 utr:MMBTU 0000037785 us-gaap:EnergyRelatedDerivativeMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 fmc:ForeignCurrencyAndEnergyContractsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 us-gaap:NondesignatedMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000037785 us-gaap:NondesignatedMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember 2019-12-31 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2019-07-01 2019-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-07-01 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2020-07-01 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2019-01-01 2019-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-09-30 0000037785 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000037785 fmc:CostOfSalesAndServicesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000037785 fmc:CostOfSalesAndServicesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2019-07-01 2019-09-30 0000037785 fmc:CostOfSalesAndServicesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000037785 fmc:CostOfSalesAndServicesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2019-01-01 2019-09-30 0000037785 us-gaap:NondesignatedMember 2020-07-01 2020-09-30 0000037785 us-gaap:NondesignatedMember 2019-07-01 2019-09-30 0000037785 us-gaap:NondesignatedMember 2020-01-01 2020-09-30 0000037785 us-gaap:NondesignatedMember 2019-01-01 2019-09-30 0000037785 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2020-09-30 0000037785 us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0000037785 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000037785 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000037785 us-gaap:FinancialGuaranteeMember 2020-09-30 0000037785 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2020-09-30 0000037785 us-gaap:SubsequentEventMember 2020-10-28 2020-10-28 0000037785 us-gaap:SubsequentEventMember fmc:IsagroMember 2020-10-02 2020-10-02 0000037785 srt:ScenarioForecastMember us-gaap:SubsequentEventMember fmc:IsagroMember 2020-10-01 2020-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________
FORM 10-Q
_______________________________________________________________________

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2020
or

☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______ to _______
Commission File Number 1-2376
__________________________________________________________________________
FMC CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________

Delaware |  | 94-0479804
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
2929 Walnut Street | Philadelphia | Pennsylvania | 19104
(Address of principal executive offices) |  |  | (Zip Code)

Registrant’s telephone number, including area code: 215-299-6000
__________________________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Common Stock, par value $0.10 per share |  | FMC |  | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☒ |  | Accelerated filer |  | ☐
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☐
|  |  |  | Emerging growth company |  | ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒
As of September 30, 2020, there were 129,757,157 of the registrant's common shares outstanding.

FMC CORPORATION
INDEX

| Page No.
Part I - FINANCIAL INFORMATION | 3
Item 1. Financial Statements | 3
Condensed Consolidated Statements of Income (Loss) - Three and nine months ended September 30, 2020 and 2019 (unaudited) | 3
Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and nine months ended September 30, 2020 and 2019 (unaudited) | 4
Condensed Consolidated Balance Sheets - September 30, 2020 and December 31, 2019 (unaudited) | 5
Condensed Consolidated Statements of Cash Flows - Nine months ended September 30, 2020 and 2019 (unaudited) | 6
Condensed Consolidated Statements of Changes in Equity - Three and nine months ended September 30, 2020 and 2019 (unaudited) | 8
Notes to Condensed Consolidated Financial Statements (unaudited) | 10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 37
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 57
Item 4. Controls and Procedures | 57
Part II - OTHER INFORMATION | 59
Item 1. Legal Proceedings | 59
Item 1A. Risk Factors | 59
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 60
Item 5. Other Information | 60
Item 6. Exhibits | 60
Signatures | 61

2

PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
(in Millions, Except Per Share Data) | (unaudited) |  | (unaudited)
Revenue | $ | 1,084.6 |  |  | $ | 1,014.3 |  |  | $ | 3,489.9 |  |  | $ | 3,412.5 |
Costs and Expenses |  |  |  |  |  |  |
Costs of sales and services | 618.2 |  |  | 581.9 |  |  | 1,939.3 |  |  | 1,884.9 |
Gross margin | $ | 466.4 |  |  | $ | 432.4 |  |  | $ | 1,550.6 |  |  | $ | 1,527.6 |
Selling, general and administrative expenses | 187.7 |  |  | 188.3 |  |  | 548.1 |  |  | 569.1 |
Research and development expenses | 71.7 |  |  | 77.4 |  |  | 203.3 |  |  | 221.7 |
Restructuring and other charges (income) | 11.0 |  |  | 6.8 |  |  | 43.9 |  |  | 27.3 |
Total costs and expenses | $ | 888.6 |  |  | $ | 854.4 |  |  | $ | 2,734.6 |  |  | $ | 2,703.0 |
Income from continuing operations before non-operating pension and postretirement charges (income), interest expense, net and income taxes | $ | 196.0 |  |  | $ | 159.9 |  |  | $ | 755.3 |  |  | $ | 709.5 |
Non-operating pension and postretirement charges (income) | 11.6 |  |  | (1.2) |  |  | 16.0 |  |  | 5.5 |
Interest expense, net | 35.5 |  |  | 41.6 |  |  | 117.0 |  |  | 115.6 |
Income (loss) from continuing operations before income taxes | $ | 148.9 |  |  | $ | 119.5 |  |  | $ | 622.3 |  |  | $ | 588.4 |
Provision (benefit) for income taxes | 18.4 |  |  | 8.7 |  |  | 82.3 |  |  | 75.6 |
Income (loss) from continuing operations | $ | 130.5 |  |  | $ | 110.8 |  |  | $ | 540.0 |  |  | $ | 512.8 |
Discontinued operations, net of income taxes | (18.4) |  |  | (21.3) |  |  | (36.7) |  |  | (29.8) |
Net income (loss) | $ | 112.1 |  |  | $ | 89.5 |  |  | $ | 503.3 |  |  | $ | 483.0 |
Less: Net income (loss) attributable to noncontrolling interests | 0.7 |  |  | (0.9) |  |  | 1.3 |  |  | 2.4 |
Net income (loss) attributable to FMC stockholders | $ | 111.4 |  |  | $ | 90.4 |  |  | $ | 502.0 |  |  | $ | 480.6 |
Amounts attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations, net of income taxes | $ | 129.8 |  |  | $ | 111.7 |  |  | $ | 538.7 |  |  | $ | 510.4 |
Discontinued operations, net of income taxes | (18.4) |  |  | (21.3) |  |  | (36.7) |  |  | (29.8) |
Net income (loss) attributable to FMC stockholders | $ | 111.4 |  |  | $ | 90.4 |  |  | $ | 502.0 |  |  | $ | 480.6 |
Basic earnings (loss) per common share attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.00 |  |  | $ | 0.85 |  |  | $ | 4.14 |  |  | $ | 3.88 |
Discontinued operations | (0.14) |  |  | (0.16) |  |  | (0.28) |  |  | (0.22) |
Net income (loss) attributable to FMC stockholders | $ | 0.86 |  |  | $ | 0.69 |  |  | $ | 3.86 |  |  | $ | 3.66 |
Diluted earnings (loss) per common share attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.99 |  |  | $ | 0.85 |  |  | $ | 4.12 |  |  | $ | 3.85 |
Discontinued operations | (0.14) |  |  | (0.16) |  |  | (0.28) |  |  | (0.22) |
Net income (loss) attributable to FMC stockholders | $ | 0.85 |  |  | $ | 0.69 |  |  | $ | 3.84 |  |  | $ | 3.63 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
3

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
(in Millions) | (unaudited) |  | (unaudited)
Net income (loss) | $ | 112.1 |  |  | $ | 89.5 |  |  | $ | 503.3 |  |  | $ | 483.0 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Foreign currency adjustments: |  |  |  |  |  |  |
Foreign currency translation gain (loss) arising during the period | $ | 41.7 |  |  | $ | (47.2) |  |  | $ | 27.8 |  |  | $ | (42.7) |
Total foreign currency translation adjustments (1) | $ | 41.7 |  |  | $ | (47.2) |  |  | $ | 27.8 |  |  | $ | (42.7) |
Derivative instruments: |  |  |  |  |  |  |
Unrealized hedging gains (losses) and other, net of tax expense (benefit) of $(3.9) and $3.0 for the three and nine months ended September 30, 2020 and $(8.2) and $(17.1) for the three and nine months ended September 30, 2019, respectively | $ | 3.9 |  |  | $ | (25.5) |  |  | $ | 29.3 |  |  | $ | (62.0) |
Reclassification of deferred hedging (gains) losses and other, included in net income, net of tax (expense) benefit of $3.4 and $(0.5) for the three and nine months ended September 30, 2020 and $(0.6) and $(2.3) for the three and nine months ended September 30, 2019, respectively (2) | 3.3 |  |  | (1.2) |  |  | (15.4) |  |  | (8.0) |
Total derivative instruments, net of tax expense (benefit) of $(0.5) and $2.5 for the three and nine months ended September 30, 2020 and $(8.8) and $(19.4) for the three and nine months ended September 30, 2019, respectively | $ | 7.2 |  |  | $ | (26.7) |  |  | $ | 13.9 |  |  | $ | (70.0) |
Pension and other postretirement benefits: |  |  |  |  |  |  |
Unrealized actuarial gains (losses) and prior service (costs) credits, net of tax expense (benefit) of $(0.1) and zero for the three and nine months ended September 30, 2020 and zero and zero for the three and nine months ended September 30, 2019, respectively | $ | 0.2 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Reclassification of net actuarial and other (gain) loss and amortization of prior service costs, included in net income, net of tax (expense) benefit of $2.3 and $3.2 for the three and nine months ended September 30, 2020 and $0.1 and $1.9 for the three and nine months ended September 30, 2019, respectively (2) | 8.8 |  |  | 0.3 |  |  | 12.0 |  |  | 7.0 |
Total pension and other postretirement benefits, net of tax expense (benefit) of $2.2 and $3.2 for the three and nine months ended September 30, 2020 and $0.1 and $1.9 for the three and nine months ended September 30, 2019, respectively | $ | 9.0 |  |  | $ | 0.3 |  |  | $ | 12.0 |  |  | $ | 7.0 |
Other comprehensive income (loss), net of tax | $ | 57.9 |  |  | $ | (73.6) |  |  | $ | 53.7 |  |  | $ | (105.7) |
Comprehensive income (loss) | $ | 170.0 |  |  | $ | 15.9 |  |  | $ | 557.0 |  |  | $ | 377.3 |
Less: Comprehensive income (loss) attributable to the noncontrolling interest | 1.3 |  |  | (1.2) |  |  | 0.9 |  |  | 0.5 |
Comprehensive income (loss) attributable to FMC stockholders | $ | 168.7 |  |  | $ | 17.1 |  |  | $ | 556.1 |  |  | $ | 376.8 |

____________________
(1)Income taxes are not provided for outside basis differences inherent in our investments in subsidiaries because the investments and related unremitted earnings are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal or remittance.
(2)For more detail on the components of these reclassifications and the affected line item in the condensed consolidated statements of income (loss) see Note 15.
The accompanying notes are an integral part of these condensed consolidated financial statements.
4

FMC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

(in Millions, Except Share and Par Value Data) | September 30, 2020 |  | December 31, 2019
ASSETS | (unaudited)
Current assets |  |  |
Cash and cash equivalents | $ | 297.1 |  |  | $ | 339.1 |
Trade receivables, net of allowance of $22.5 in 2020 and $26.3 in 2019 | 2,137.9 |  |  | 2,231.2 |
Inventories | 1,155.5 |  |  | 1,017.0 |
Prepaid and other current assets | 424.7 |  |  | 487.5 |
Total current assets | $ | 4,015.2 |  |  | $ | 4,074.8 |
Investments | 1.7 |  |  | 0.7 |
Property, plant and equipment, net | 739.2 |  |  | 758.0 |
Goodwill | 1,464.2 |  |  | 1,467.5 |
Other intangibles, net | 2,610.6 |  |  | 2,629.0 |
Other assets including long-term receivables, net | 684.6 |  |  | 685.3 |
Deferred income taxes | 256.7 |  |  | 257.4 |
Total assets | $ | 9,772.2 |  |  | $ | 9,872.7 |
LIABILITIES AND EQUITY |  |  |
Current liabilities |  |  |
Short-term debt and current portion of long-term debt | $ | 194.1 |  |  | $ | 227.7 |
Accounts payable, trade and other | 757.2 |  |  | 900.1 |
Advance payments from customers | 5.5 |  |  | 492.7 |
Accrued and other liabilities | 683.6 |  |  | 680.6 |
Accrued customer rebates | 530.7 |  |  | 280.6 |
Guarantees of vendor financing | 97.0 |  |  | 75.7 |
Accrued pension and other postretirement benefits, current | 4.3 |  |  | 4.3 |
Income taxes | 95.9 |  |  | 62.2 |
Total current liabilities | $ | 2,368.3 |  |  | $ | 2,723.9 |
Long-term debt, less current portion | 3,028.3 |  |  | 3,031.1 |
Accrued pension and other postretirement benefits, long-term | 42.0 |  |  | 44.2 |
Environmental liabilities, continuing and discontinued | 424.4 |  |  | 470.5 |
Deferred income taxes | 345.4 |  |  | 333.2 |
Other long-term liabilities | 595.4 |  |  | 708.4 |
Commitments and contingent liabilities (Note 19) |  |  |
Equity |  |  |
Preferred stock, no par value, authorized 5,000,000 shares; no shares issued in 2020 or 2019 | $ | — |  |  | $ | — |
Common stock, $0.10 par value, authorized 260,000,000 shares; 185,983,792 issued shares in 2020 and 2019 | 18.6 |  |  | 18.6 |
Capital in excess of par value of common stock | 854.7 |  |  | 829.7 |
Retained earnings | 4,519.3 |  |  | 4,188.8 |
Accumulated other comprehensive income (loss) | (357.9) |  |  | (412.0) |
Treasury stock, common, at cost - 2020: 56,226,635 shares, 2019: 56,859,498 shares | (2,090.2) |  |  | (2,092.8) |
Total FMC stockholders’ equity | $ | 2,944.5 |  |  | $ | 2,532.3 |
Noncontrolling interests | 23.9 |  |  | 29.1 |
Total equity | $ | 2,968.4 |  |  | $ | 2,561.4 |
Total liabilities and equity | $ | 9,772.2 |  |  | $ | 9,872.7 |

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

| Nine Months Ended September 30,
2020 |  | 2019
(in Millions) | (unaudited)
Cash provided (required) by operating activities of continuing operations: |  |  |
Net income (loss) | $ | 503.3 |  |  | $ | 483.0 |
Discontinued operations, net of income taxes | 36.7 |  |  | 29.8 |
Income (loss) from continuing operations | $ | 540.0 |  |  | $ | 512.8 |
Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations: |  |  |
Depreciation and amortization | $ | 120.7 |  |  | $ | 111.1 |
Restructuring and other charges (income) | 43.9 |  |  | 27.3 |
Deferred income taxes | 2.6 |  |  | (3.6) |
Pension and other postretirement benefits | 19.7 |  |  | 8.2 |
Share-based compensation | 15.2 |  |  | 19.2 |
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: |  |  |
Trade receivables, net | 77.9 |  |  | 118.7 |
Guarantees of vendor financing | 21.3 |  |  | 5.9 |
Advance payments from customers | (487.4) |  |  | (439.1) |
Accrued customer rebates | 247.1 |  |  | 186.2 |
Inventories | (141.7) |  |  | (151.8) |
Accounts payable, trade and other | (142.8) |  |  | (119.4) |
Income taxes | 15.7 |  |  | (64.0) |
Pension and other postretirement benefit contributions | (3.6) |  |  | (9.8) |
Environmental spending, continuing, net of recoveries | 6.9 |  |  | (8.7) |
Restructuring and other spending (1) | (11.6) |  |  | (15.3) |
Transaction and integration costs | (53.3) |  |  | (61.5) |
Change in other operating assets and liabilities, net (2) | 42.9 |  |  | (50.4) |
Cash provided (required) by operating activities of continuing operations | $ | 313.5 |  |  | $ | 65.8 |
Cash provided (required) by operating activities of discontinued operations: |  |  |
Environmental spending, discontinued, net of recoveries | $ | (43.6) |  |  | $ | (27.9) |
Other discontinued spending | (22.5) |  |  | (17.5) |
Operating activities of discontinued operations, net of divestiture costs | (0.2) |  |  | 9.2 |
Cash provided (required) by operating activities of discontinued operations | $ | (66.3) |  |  | $ | (36.2) |

____________________
(1) The restructuring and other spending amount includes spending of $3.1 million related to the Furadan® asset retirement obligations. For detail on restructuring activities which commenced prior to 2020, see Note 9 to our consolidated financial statements included within our 2019 Form 10-K.
(2) Changes in all periods primarily represent timing of payments associated with all other operating assets and liabilities.
The accompanying notes are an integral part of these condensed consolidated financial statements.
(continued)
6

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

| Nine Months Ended September 30,
2020 |  | 2019
(in Millions) | (unaudited)
Cash provided (required) by investing activities of continuing operations: |  |  |
Capital expenditures | $ | (35.2) |  |  | $ | (56.8) |
Investment in Enterprise Resource Planning system | (42.2) |  |  | (42.0) |
Other investing activities | (23.1) |  |  | (20.7) |
Cash provided (required) by investing activities of continuing operations | $ | (100.5) |  |  | $ | (119.5) |
Cash provided (required) by investing activities of discontinued operations: |  |  |
Proceeds from disposal of property, plant and equipment | $ | 1.1 |  |  | $ | 26.2 |
Other discontinued investing activities | — |  |  | (17.0) |
Cash provided (required) by investing activities of discontinued operations | $ | 1.1 |  |  | $ | 9.2 |
Cash provided (required) by financing activities of continuing operations: |  |  |
Increase (decrease) in short-term debt | $ | (35.6) |  |  | $ | 17.4 |
Repayments of long-term debt | — |  |  | (601.6) |
Financing fees | (3.5) |  |  | (95.2) |
Proceeds from borrowings of long-term debt | 17.2 |  |  | 1,500.0 |
Acquisitions of noncontrolling interests | (7.4) |  |  | — |
Distributions to noncontrolling interests | (1.3) |  |  | — |
Issuances of common stock, net | 23.0 |  |  | 28.7 |
Dividends paid (3) | (171.3) |  |  | (158.3) |
Repurchases of common stock under publicly announced program | — |  |  | (300.0) |
Other repurchases of common stock | (7.5) |  |  | (16.2) |
Cash provided (required) by financing activities of continuing operations | $ | (186.4) |  |  | $ | 374.8 |
Cash provided (required) by financing activities of discontinued operations: |  |  |
Payment of Livent external debt | $ | — |  |  | $ | (27.0) |
Cash transfer to Livent due to spin | — |  |  | (10.2) |
Cash provided (required) by financing activities of discontinued operations | $ | — |  |  | $ | (37.2) |
Effect of exchange rate changes on cash and cash equivalents | (3.4) |  |  | 1.1 |
Increase (decrease) in cash and cash equivalents | $ | (42.0) |  |  | $ | 258.0 |
Cash and cash equivalents of continuing operations, beginning of period | $ | 339.1 |  |  | $ | 134.4 |
Cash and cash equivalents of discontinued operations, beginning of period | — |  |  | 27.3 |
Cash and cash equivalents, beginning of period | $ | 339.1 |  |  | $ | 161.7 |
Cash and cash equivalents, end of period | $ | 297.1 |  |  | $ | 419.7 |

____________________
(3) See Note 15 regarding the quarterly cash dividend.
Supplemental disclosure of cash flow information: Cash paid for interest, net of capitalized interest was $104.2 million and $114.4 million, and income taxes paid, net of refunds were $63.3 million and $109.6 million for the nine months ended September 30, 2020 and 2019, respectively. Non-cash additions to property, plant and equipment and other assets were $15.3 million and $3.9 million for the nine months ended September 30, 2020 and 2019, respectively.
The accompanying notes are an integral part of these condensed consolidated financial statements.
7

FMC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(UNAUDITED)

| FMC Stockholders’ Equity |  |  |  |
(in Millions, Except Per Share Data) | Common Stock, $0.10 Par Value |  | Capital In Excess of Par |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Treasury Stock |  | Non-controlling Interest |  | Total Equity
Balance at December 31, 2019 | $ | 18.6 |  |  | $ | 829.7 |  |  | $ | 4,188.8 |  |  | $ | (412.0) |  |  | $ | (2,092.8) |  |  | $ | 29.1 |  |  | $ | 2,561.4 |
Net income (loss) | — |  |  | — |  |  | 206.2 |  |  | — |  |  | — |  |  | — |  |  | 206.2 |
Stock compensation plans | — |  |  | 10.5 |  |  | — |  |  | — |  |  | 6.0 |  |  | — |  |  | 16.5 |
Shares for benefit plan trust | — |  |  | — |  |  | — |  |  | — |  |  | (0.4) |  |  | — |  |  | (0.4) |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 1.6 |  |  | — |  |  | — |  |  | 1.6 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | 17.2 |  |  | — |  |  | — |  |  | 17.2 |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | (33.6) |  |  | — |  |  | (1.8) |  |  | (35.4) |
Dividends ($0.44 per share) | — |  |  | — |  |  | (57.1) |  |  | — |  |  | — |  |  | — |  |  | (57.1) |
Repurchases of common stock | — |  |  | — |  |  | — |  |  | — |  |  | (7.3) |  |  | — |  |  | (7.3) |
Balance at March 31, 2020 | $ | 18.6 |  |  | $ | 840.2 |  |  | $ | 4,337.9 |  |  | $ | (426.8) |  |  | $ | (2,094.5) |  |  | $ | 27.3 |  |  | $ | 2,702.7 |
Net income (loss) | — |  |  | — |  |  | 184.4 |  |  | — |  |  | — |  |  | 0.6 |  |  | 185.0 |
Stock compensation plans | — |  |  | 6.3 |  |  | — |  |  | — |  |  | 1.9 |  |  | — |  |  | 8.2 |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 1.4 |  |  | — |  |  | — |  |  | 1.4 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | (10.5) |  |  | — |  |  | — |  |  | (10.5) |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | 20.7 |  |  | — |  |  | 0.8 |  |  | 21.5 |
Dividends ($0.44 per share) | — |  |  | — |  |  | (57.2) |  |  | — |  |  | — |  |  | — |  |  | (57.2) |
Repurchases of common stock | — |  |  | — |  |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | (0.2) |
Balance at June 30, 2020 | $ | 18.6 |  |  | $ | 846.5 |  |  | $ | 4,465.1 |  |  | $ | (415.2) |  |  | $ | (2,092.8) |  |  | $ | 28.7 |  |  | $ | 2,850.9 |
Net income | — |  |  | — |  |  | 111.4 |  |  | — |  |  | — |  |  | 0.7 |  |  | 112.1 |
Stock compensation plans | — |  |  | 10.8 |  |  | — |  |  | — |  |  | 2.6 |  |  | — |  |  | 13.4 |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 9.0 |  |  | — |  |  | — |  |  | 9.0 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | 7.2 |  |  | — |  |  | — |  |  | 7.2 |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | 41.1 |  |  | — |  |  | 0.6 |  |  | 41.7 |
Dividends ($0.44 per share) | — |  |  | — |  |  | (57.2) |  |  | — |  |  | — |  |  | — |  |  | (57.2) |
Acquisition of noncontrolling interests (2) | — |  |  | (2.6) |  |  | — |  |  | — |  |  | — |  |  | (4.8) |  |  | (7.4) |
Distributions to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1.3) |  |  | (1.3) |
Balance at September 30, 2020 | $ | 18.6 |  |  | $ | 854.7 |  |  | $ | 4,519.3 |  |  | $ | (357.9) |  |  | $ | (2,090.2) |  |  | $ | 23.9 |  |  | $ | 2,968.4 |

____________________
(1)See condensed consolidated statements of comprehensive income (loss).
(2)In July 2020, we purchased the remaining 49 percent ownership interest in our Indonesia joint venture, PT Bina Guna Kimia ("BGK"), for $7.4 million which increased our ownership from 51 percent percent to 100 percent.
8

| FMC Stockholders’ Equity |  |  |  |
(in Millions, Except Per Share Data) | Common Stock, $0.10 Par Value |  | Capital In Excess of Par |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Treasury Stock |  | Non-controlling Interest |  | Total Equity
Balance at December 31, 2018 | $ | 18.6 |  |  | $ | 776.2 |  |  | $ | 4,334.3 |  |  | $ | (308.9) |  |  | $ | (1,699.1) |  |  | $ | 89.3 |  |  | $ | 3,210.4 |
Adoption of accounting standards | — |  |  | — |  |  | 55.5 |  |  | (53.1) |  |  | — |  |  | — |  |  | 2.4 |
Net income (loss) | — |  |  | — |  |  | 215.7 |  |  | — |  |  | — |  |  | 1.5 |  |  | 217.2 |
Stock compensation plans | — |  |  | 9.4 |  |  | — |  |  | — |  |  | 7.2 |  |  | — |  |  | 16.6 |
Shares for benefit plan trust | — |  |  | — |  |  | — |  |  | — |  |  | (1.1) |  |  | — |  |  | (1.1) |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 3.4 |  |  | — |  |  | — |  |  | 3.4 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | (2.7) |  |  | — |  |  | — |  |  | (2.7) |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | (2.1) |  |  | — |  |  | (0.3) |  |  | (2.4) |
Dividends ($0.40 per share) | — |  |  | — |  |  | (52.8) |  |  | — |  |  | — |  |  | — |  |  | (52.8) |
Repurchases of common stock | — |  |  | — |  |  | — |  |  | — |  |  | (114.2) |  |  | — |  |  | (114.2) |
Divestiture of Livent (2) | — |  |  | — |  |  | (464.3) |  |  | 39.0 |  |  | — |  |  | (59.7) |  |  | (485.0) |
Balance at March 31, 2019 | $ | 18.6 |  |  | $ | 785.6 |  |  | $ | 4,088.4 |  |  | $ | (324.4) |  |  | $ | (1,807.2) |  |  | $ | 30.8 |  |  | $ | 2,791.8 |
Net income (loss) | — |  |  | — |  |  | 174.5 |  |  | — |  |  | — |  |  | 1.8 |  |  | 176.3 |
Stock compensation plans | — |  |  | 8.3 |  |  | — |  |  | — |  |  | 1.3 |  |  | — |  |  | 9.6 |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 3.3 |  |  | — |  |  | — |  |  | 3.3 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | (40.6) |  |  | — |  |  | — |  |  | (40.6) |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | 8.2 |  |  | — |  |  | (1.3) |  |  | 6.9 |
Dividends ($0.40 per share) | — |  |  | — |  |  | (52.4) |  |  | — |  |  | — |  |  | — |  |  | (52.4) |
Repurchases of common stock | — |  |  | — |  |  | — |  |  | — |  |  | (100.0) |  |  | — |  |  | (100.0) |
Balance at June 30, 2019 | $ | 18.6 |  |  | $ | 793.9 |  |  | $ | 4,210.5 |  |  | $ | (353.5) |  |  | $ | (1,905.9) |  |  | $ | 31.3 |  |  | $ | 2,794.9 |
Net income (loss) | — |  |  | — |  |  | 90.4 |  |  | — |  |  | — |  |  | (0.9) |  |  | 89.5 |
Stock compensation plans | — |  |  | 15.4 |  |  | — |  |  | — |  |  | 5.0 |  |  | — |  |  | 20.4 |
Shares for benefit plan trust | — |  |  | — |  |  | — |  |  | — |  |  | 0.1 |  |  | — |  |  | 0.1 |
Net pension and other benefit actuarial gains (losses) and prior service costs, net of income tax (1) | — |  |  | — |  |  | — |  |  | 0.3 |  |  | — |  |  | — |  |  | 0.3 |
Net hedging gains (losses) and other, net of income tax (1) | — |  |  | — |  |  | — |  |  | (26.7) |  |  | — |  |  | — |  |  | (26.7) |
Foreign currency translation adjustments (1) | — |  |  | — |  |  | — |  |  | (46.9) |  |  | — |  |  | (0.3) |  |  | (47.2) |
Dividends ($0.40 per share) | — |  |  | — |  |  | (51.9) |  |  | — |  |  | — |  |  | — |  |  | (51.9) |
Repurchases of common stock | — |  |  | — |  |  | — |  |  | — |  |  | (100.1) |  |  | — |  |  | (100.1) |
Balance at September 30, 2019 | $ | 18.6 |  |  | $ | 809.3 |  |  | $ | 4,249.0 |  |  | $ | (426.8) |  |  | $ | (2,000.9) |  |  | $ | 30.1 |  |  | $ | 2,679.3 |

____________________
(1)See condensed consolidated statements of comprehensive income (loss).
(2)Represents the effects of the distribution of FMC Lithium.
The accompanying notes are an integral part of these condensed consolidated financial statements.
9

FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited)
Note 1: Financial Information and Accounting Policies
In our opinion the condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") applicable to interim period financial statements and reflect all adjustments necessary for a fair statement of results of operations for the three and nine months ended September 30, 2020 and 2019, cash flows for the nine months ended September 30, 2020 and 2019, changes in equity for the three and nine months ended September 30, 2020 and 2019, and our financial positions as of September 30, 2020 and December 31, 2019. All such adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the Notes. The results of operations for the three and nine months ended September 30, 2020 and 2019 are not necessarily indicative of the results of operations for the full year. The condensed consolidated balance sheets as of September 30, 2020 and December 31, 2019, and the related condensed consolidated statements of income (loss) and condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2020 and 2019, condensed consolidated statements of cash flows for the nine months ended September 30, 2020 and 2019, and condensed consolidated statements of changes in equity for the three and nine months ended September 30, 2020 and 2019 have been reviewed by our independent registered public accountants. The review is described more fully in their report included herein. Our accounting policies are set forth in detail in Note 1 to the consolidated financial statements included with our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2019 (the "2019 Form 10-K").
Given the COVID-19 pandemic, many countries, including the United States, subsequently imposed restrictions on both travel and business closures in an effort to mitigate the spread of COVID-19. As an agriculture sciences company, we are considered an "essential" industry in the countries in which we operate and have avoided significant plant closures and all our facilities are operational. While we have maintained business continuity and sustained our operations, we do not yet know the full extent of the disruptions on either our business and operations or the global economy nor the duration of the pandemic and its adverse effects.
Note 2: Recently Issued and Adopted Accounting Pronouncements and Regulatory Items
New accounting guidance and regulatory items
In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional guidance for a limited period of time to ease the potential burden in accounting for contracts and hedging relationships affected by reference rate reform. This applies to contracts that reference LIBOR or another rate that is expected to be discontinued as a result of rate reform and have modified terms that affect or have the potential to affect the amount and timing of contractual cash flows resulting from the discontinuance of reference rate. The new standard is currently effective and upon adoption may be applied prospectively through December 31, 2022. We are evaluating the impacts this standard will have on accounting for contracts and hedging relationships but do not believe it will have a material impact on our consolidated financial statements.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions and simplification in several other areas. The new standard is effective for fiscal years beginning after December 15, 2020 (i.e., a January 1, 2021 effective date). We are evaluating the effect this guidance will have on our consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-14, Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans. The amendments in this ASU modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The new standard is effective for fiscal years ending after December 15, 2020. This standard will eliminate previously required disclosures such as the amounts in AOCI expected to be recognized over the next year and the sensitivity analysis on the change in the assumed healthcare cost trend rate. Additional disclosures may arise in the future if there are any significant gains and losses affecting benefit obligations. We believe the adoption will not have a material impact on our consolidated financial statements other than potential disclosure requirements.
10

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Recently adopted accounting guidance
In August 2018, the FASB issued ASU No. 2018-15, Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new standard became effective for fiscal years beginning after December 15, 2019 (i.e. a January 1, 2020 effective date). There was no material impact to our consolidated financial statements upon adoption.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU changes the subsequent measurement of goodwill impairment by eliminating Step 2 from the impairment test. Under the new guidance, an entity will measure impairment using the difference between the carrying amount and the fair value of the reporting unit. The new standard became effective for fiscal years beginning after December 15, 2019 (i.e. a January 1, 2020 effective date), with early adoption permitted for goodwill impairment tests with measurement dates after January 1, 2017. There was no material impact to our consolidated financial statements upon adoption.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 replaces the incurred loss impairment methodology with a current expected credit loss ("CECL") model that immediately recognizes an estimate of credit losses that are expected to occur over the life of the financial instrument, including trade receivables. The update is intended to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. The new standard became effective January 1, 2020. As a result of the adoption, we have refined our allowance for doubtful trade receivables methodology which considers current economic conditions as well as forward-looking expectations about expected credit losses. Our accounting policy, as set forth in detail in Note 1 within the 2019 Form 10-K, follows a consistent methodology and incorporates the additional requirements under the new standard’s CECL framework. The adoption of the new standard did not result in a material impact to our consolidated financial statements.
Note 3: Revenue Recognition
Disaggregation of revenue
We disaggregate revenue from contracts with customers by geographical areas and major product categories. We have three major agricultural pesticide product categories: insecticides, herbicides, and fungicides. The disaggregated revenue tables are shown below for the three and nine months ended September 30, 2020 and 2019.
The following table provides information about disaggregated revenue by major geographical region:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
North America | $ | 212.3 |  |  | $ | 196.3 |  |  | $ | 851.8 |  |  | $ | 848.1 |
Latin America | 464.9 |  |  | 460.2 |  |  | 985.3 |  |  | 923.4 |
Europe, Middle East & Africa (EMEA) | 152.8 |  |  | 138.4 |  |  | 833.5 |  |  | 854.7 |
Asia | 254.6 |  |  | 219.4 |  |  | 819.3 |  |  | 786.3 |
Total Revenue | $ | 1,084.6 |  |  | $ | 1,014.3 |  |  | $ | 3,489.9 |  |  | $ | 3,412.5 |

The following table provides information about disaggregated revenue by major product category:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Insecticides | $ | 746.8 |  |  | $ | 649.7 |  |  | $ | 2,147.1 |  |  | $ | 2,063.4 |
Herbicides | 214.7 |  |  | 199.0 |  |  | 922.5 |  |  | 910.0 |
Fungicides | 59.4 |  |  | 61.3 |  |  | 204.5 |  |  | 190.0 |
Other | 63.7 |  |  | 104.3 |  |  | 215.8 |  |  | 249.1 |
Total Revenue | $ | 1,084.6 |  |  | $ | 1,014.3 |  |  | $ | 3,489.9 |  |  | $ | 3,412.5 |

11

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
We earn revenue from the sale of a wide range of products to a diversified base of customers around the world. Our portfolio is comprised of three major pesticide categories: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The majority of our product lines consist of insecticides and herbicides, with a smaller portfolio of fungicides mainly used in high value crop segments. Our insecticides are used to control a wide spectrum of pests, while our herbicide portfolio primarily targets a large variety of difficult-to-control weeds. Products in the other category include various agricultural products such as smaller classes of pesticides, growth promoters, and soil enhancements.
Sale of Goods
Revenue from product sales is recognized when (or as) we satisfy a performance obligation by transferring the promised goods to a customer, that is, when control of the good transfers to the customer. The customer is then invoiced at the agreed-upon price with payment terms generally ranging from 30 to 90 days, with some regions providing terms longer than 90 days. We do not typically give payment terms that exceed 360 days; however, in certain geographical regions such as Latin America, these terms may be given in limited circumstances. Additionally, a timing difference of over one year can exist between when products are delivered to the customer and when payment is received from the customer in these regions; however, the effect of these sales is not material to the financial statements as a whole. Furthermore, we have assessed the circumstances and arrangements in these regions and determined that the contracts with these customers do not contain a significant financing component.
In determining when the control of goods is transferred, we typically assess, among other things, the transfer of risk and title and the shipping terms of the contract. The transfer of title and risk typically occurs either upon shipment to the customer or upon receipt by the customer. As such, we typically recognize revenue when goods are shipped based on the relevant Incoterm for the product order, or in some regions, when delivery to the customer’s requested destination has occurred. When we perform shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to delivery), they are considered as fulfillment activities, and accordingly, the costs are accrued for when the related revenue is recognized. For FOB shipping point terms, revenue is recognized at the time of shipment since the customer gains control at this point in time.
We record amounts billed for shipping and handling fees as revenue. Costs incurred for shipping and handling are recorded as costs of sales and services. Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements. We record a liability until remitted to the respective taxing authority.
Sales Incentives and Other Variable Considerations
As a part of our customary business practice, we offer a number of sales incentives to our customers including volume discounts, retailer incentives, and prepayment options. The variable considerations given can differ by products, support levels and other eligibility criteria. For all such contracts that include any variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining the transaction price for these considerations requires significant judgment, we have significant historical experience with incentives provided to customers and estimate the expected consideration considering historical patterns of incentive payouts. These estimates are reassessed each reporting period as required.
In addition to the variable considerations described above, in certain instances, we may require our customers to meet certain volume thresholds within their contract term. We estimate what amount of variable consideration should be included in the transaction price at contract inception and continually reassess this estimation each reporting period to determine situations when the minimum volume thresholds will not be met.
Right of Return
We extend an assurance warranty offering customers a right of refund or exchange in case delivered product does not conform to specifications. Additionally, in certain regions and arrangements, we may offer a right of return for a specified period. Both instances are accounted for as a right of return and transaction price is adjusted for an estimate of expected returns. Replacement products are accounted for under the warranty guidance if the customer exchanges one product for another of the
12

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
same kind, quality, and price. We have significant experience with historical return patterns and use this experience to include returns in the estimate of transaction price.
Contract asset and contract liability balances
We satisfy our obligations by transferring goods and services in exchange for consideration from customers. The timing of performance sometimes differs from the timing the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract liability. We recognize a contract liability if the customer's payment of consideration is received prior to completion of our related performance obligation.
The following table presents the opening and closing balances of our receivables, net of allowances and contract liabilities from contracts with customers:

(in Millions) | Balance as of December 31, 2019 |  | Balance as of September 30, 2020 |  | Increase (Decrease)
Receivables from contracts with customers, net of allowances | $ | 2,354.3 |  |  | $ | 2,247.5 |  |  | $ | (106.8) |
Contract liabilities: Advance payments from customers | 492.7 |  |  | 5.5 |  |  | (487.2) |

The amount of revenue recognized in the nine months ended September 30, 2020 that was included in the opening contract liability balance is $487.2 million.
The balance of receivables from contracts with customers listed in the table above include both current trade receivables and long-term receivables, net of allowance for doubtful accounts. The allowance for receivables represents our best estimate of the probable losses associated with potential customer defaults. We determine the allowance based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. The change in allowance for doubtful accounts for both current trade receivables and long-term receivables is representative of the impairment of receivables as of September 30, 2020. Refer to Note 7 for further information.
We periodically enter into prepayment arrangements with customers and receive advance payments for product to be delivered in future periods. Prepayment terms are extended to customers/distributors in order to capitalize on surplus cash with growers. Growers receive bulk payments for their produce, which they leverage to buy our products from distributors through prepayment options. This in turn creates opportunity for distributors to make large prepayments to us for securing the future supply of products to be sold to growers. Prepayments are typically received in the fourth quarter of the fiscal year and are for the following marketing year indicating that the time difference between prepayment and performance of corresponding performance obligations does not exceed one year.
We recognize these prepayments as a liability under "Advance Payments from customers" on the condensed consolidated balance sheets when they are received. Revenue associated with advance payments is recognized as shipments are made and transfer of control to the customer takes place. Advance payments from customers was $492.7 million as of December 31, 2019 and $5.5 million as of September 30, 2020.
Note 4: Leases
We lease office space, vehicles and other equipment under non-cancellable leases with initial terms typically ranging from 1 to 20 years, with some leases having terms greater than 20 years. Our lease portfolio includes agreements with renewal options, purchase options and clauses for early termination based on the terms specific to the agreement.
At contract inception, we review the facts and circumstances of the arrangement to determine if the contract is a lease. We follow the guidance in ASC 842-10-15 and consider the following: whether the contract has an identified asset; if we have the right to obtain substantially all economic benefits from the asset; and if we have the right to direct the use of the underlying asset. When determining if a contract has an identified asset, we consider both explicit and implicit assets, and whether the supplier has the right to substitute the asset. When determining if we have the right to obtain substantially all economic benefits from the asset, we consider the primary outputs of the identified asset throughout the period of use and determine if we receive greater than 90 percent of those benefits. When determining if we have the right to direct the use of an underlying asset, we consider if we have the right to direct how and for what purpose the asset is used throughout the period of use and if we control the decision-making rights over the asset. All leased assets are classified as operating or finance under ASC 842. The lease term is determined as the non-cancellable period of the lease, together with all of the following: periods covered by an option to
13

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
extend the lease which are reasonably certain to be exercised, periods covered by an option to terminate the lease if the lessee is reasonably certain not to exercise that option, and periods covered by an option to extend (or not to terminate) the lease in which exercise of the option is controlled by the lessor. At commencement, we assess whether any options included in the lease are reasonably certain to be exercised by considering all economic factors relevant including, contract-based, asset-based, market-based, and company-based factors.
To determine the present value of future minimum lease payments, we use the implicit rate when readily determinable or our incremental borrowing rate at the lease commencement date. When determining our incremental borrowing rate, we consider our centralized treasury function and our current credit profile. We then make adjustments to this rate for securitization, the length of the lease term, and leases denominated in foreign currencies. Minimum lease payments are expensed over the term of the lease on a straight-line basis. Some leases may require additional contingent or variable lease payments based on factors specific to the individual agreement. Variable lease payments for which we are typically responsible for include payment of vehicle insurance, real estate taxes, and maintenance expenses.
Most leases within our portfolio are classified as operating leases under the standard. Operating leases are included in "Other assets including long-term receivables, net", "Accrued and other liabilities", and "Other long-term liabilities" in our condensed consolidated balance sheets. Operating lease right-of-use ("ROU") assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of any lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
Operating leases relate to office spaces, IT equipment, transportation equipment, machinery equipment, furniture and fixtures, and plant and facilities under non-cancellable lease agreements. Leases primarily have fixed rental periods, with many of the real estate leases requiring additional payments for property taxes and occupancy-related costs. Leases for real estate typically have initial terms ranging from 1 to 20 years, with some leases having terms greater than 20 years. Leases for non-real estate (transportation, IT) typically have initial terms ranging from 1 to 10 years. We have elected not to record short-term leases on the balance sheet whose term is 12 months or less and does not include a purchase option or extension that is reasonably certain to be exercised.
We rent or sublease a small number of assets including equipment and office space to third party companies. These third-party arrangements include a small number of TSA arrangements from recent acquisitions. We also sublease a floor of our Corporate headquarters to our former subsidiary, Livent Corporation. Rental income from all subleases is not material to our business.
The ROU asset and lease liability balances as of September 30, 2020 and December 31, 2019 were as follows:

(in Millions) | Classification | September 30, 2020 |  | December 31, 2019
Assets |  |  |  |
Operating lease ROU assets | Other assets including long-term receivables, net | $ | 150.4 |  |  | $ | 164.7 |
Liabilities |  |  |  |
Operating lease current liabilities | Accrued and other liabilities | $ | 26.3 |  |  | $ | 31.5 |
Operating lease noncurrent liabilities | Other long-term liabilities | 152.7 |  |  | 163.2 |

The components of lease expense for the three and nine months ended September 30, 2020 and 2019 were as follows:

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | Lease Cost Classification | 2020 |  | 2019 |  | 2020 |  | 2019
Lease Cost |  |  |  |  |  |  |  |
Operating lease cost | Costs of sales and services / Selling, general and administrative expenses | $ | 10.1 |  |  | $ | 11.4 |  |  | $ | 29.9 |  |  | $ | 31.4 |
Variable lease cost | Costs of sales and services / Selling, general and administrative expenses | 1.0 |  |  | 1.3 |  |  | 3.6 |  |  | 4.1 |
Total lease cost |  | $ | 11.1 |  |  | $ | 12.7 |  |  | $ | 33.5 |  |  | $ | 35.5 |

14

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

| September 30, 2020
Operating Lease Term and Discount Rate |
Weighted-average remaining lease term (years) | 9.7
Weighted-average discount rate | 4.2 | %

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Other Information |  |  |  |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |
Operating cash flows from operating leases | $ | (10.2) |  |  | $ | (10.6) |  |  | $ | (30.1) |  |  | $ | (31.2) |
Supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets: |  |  |  |  |  |  |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 3.5 |  |  | $ | 7.8 |  |  | $ | 6.4 |  |  | $ | 11.7 |

The following table represents our future minimum operating lease payments as of, and subsequent to, September 30, 2020 under ASC 842:

(in Millions) |  |  |  |  | Operating Leases Total
Maturity of Lease Liabilities |  |  |  |  |
2020 (excluding the nine months ending September 30, 2020) |  |  |  |  | $ | 9.4 |
2021 |  |  |  |  | 30.5 |
2022 |  |  |  |  | 26.3 |
2023 |  |  |  |  | 20.5 |
2024 |  |  |  |  | 17.1 |
Thereafter |  |  |  |  | 118.2 |
Total undiscounted lease payments |  |  |  |  | $ | 222.0 |
Less: Present value adjustment |  |  |  |  | (43.0) |
Present value of lease liabilities |  |  |  |  | $ | 179.0 |

Note 5: Acquisitions
DuPont Crop Protection Business
On November 1, 2017, pursuant to the terms and conditions set forth in the Transaction Agreement entered into with E. I. du Pont de Nemours and Company ("DuPont"), we completed the acquisition of certain assets relating to DuPont's Crop Protection business and research and development organization (the "DuPont Crop Protection Business") (collectively, the "DuPont Crop Protection Business Acquisition").
As part of the DuPont Crop Protection Business Acquisition, we acquired various manufacturing contracts. The manufacturing contracts have been recognized as an asset or liability to the extent the terms of the contract are favorable or unfavorable compared with market terms of the same or similar items at the date of the acquisition.
We also entered into supply agreements with DuPont, with terms of up to five years, to supply technical insecticide products required for their retained seed treatment business at cost. The unfavorable liability is recorded within both "Accrued and other liabilities" and "Other long-term liabilities" on the condensed consolidated balance sheets and is reduced and recognized to revenues within earnings as sales are made. The amount recognized in revenue for the three and nine months ended September 30, 2020 was approximately $24 million and $87 million, respectively. The amount recognized in revenue for the three and nine months ended September 30, 2019 was approximately $36 million and $85 million, respectively.
15

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Transaction-related charges
Pursuant to U.S. GAAP, costs incurred associated with acquisition activities are expensed as incurred. Historically, these costs have primarily consisted of legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of these activities. Given the significance and complexity around the integration of the DuPont Crop Protection Business, we have incurred significant costs associated with integrating the DuPont Crop Protection Business, which included planning for the exit of the transitional service agreement ("TSA") as well as the implementation of a new worldwide Enterprise Resource Planning ("ERP") system as a result of the TSA exit, the majority of which will be capitalized in accordance with the relevant accounting literature.
The following table summarizes the costs incurred associated with these activities.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
DuPont Crop Protection Business Acquisition |  |  |  |  |  |  |
Legal and professional fees (1) | $ | 14.4 |  |  | $ | 16.0 |  |  | $ | 40.4 |  |  | $ | 52.6 |
Total Transaction-related charges | $ | 14.4 |  |  | $ | 16.0 |  |  | $ | 40.4 |  |  | $ | 52.6 |
Restructuring charges |  |  |  |  |  |  |
DuPont Crop restructuring (2) | $ | 6.4 |  |  | $ | 2.6 |  |  | $ | 29.6 |  |  | $ | 13.2 |
Total DuPont Crop restructuring charges | $ | 6.4 |  |  | $ | 2.6 |  |  | $ | 29.6 |  |  | $ | 13.2 |

____________________
(1) Represents transaction costs, costs for transitional employees, other acquired employees related costs, and transactional-related costs such as legal and professional third-party fees. These charges are recorded as a component of "Selling, general and administrative expense" on the condensed consolidated statements of income (loss).
(2) See Note 10 for more information. These charges are recorded as a component of "Restructuring and other charges (income)" on the condensed consolidated statements of income (loss).
Except for the completion of certain in-flight initiatives, primarily associated with the finalization of our worldwide ERP system, we completed the integration of the DuPont Crop Protection Business as of June 30, 2020. As noted, the TSA is now terminated and the last phase of the ERP system transition went live in November 2020 with a stabilization period that will go into the first quarter of 2021. We anticipate remaining expense of approximately $15 million to $20 million for the completion of these defined in-flight initiatives over that time period. We will also have remaining in-flight restructuring charges as we complete the established DuPont Crop Restructuring program associated with integration. Refer to Note 10 for further information.
As a result of completing the implementation of our worldwide ERP system, we will have a series of delayed restructurings under a separate initiative from those discussed above. These future restructurings are the result of consolidating activities into one system as well as into several shared service centers allowing us to improve productivity and gain efficiencies in our processes. The first wave of this new initiative is anticipated to run through 2021 and is estimated to result in pre-tax severance charges of approximately $5 million to $8 million primarily due to the fact we will be performing activities in one ERP system as opposed to multiple. Severance associated with the outer years of these restructurings is not expected to be material and will be determined as we progress through the initiative.
Note 6: Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are presented in the table below:

(in Millions) |  |  |  |  |  |  | Total
Balance, December 31, 2019 |  |  |  |  |  |  | $ | 1,467.5 |
Foreign currency and other adjustments |  |  |  |  |  |  | (3.3) |
Balance, September 30, 2020 |  |  |  |  |  |  | $ | 1,464.2 |

16

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
We perform our goodwill and indefinite-lived intangible asset impairment tests at least annually. Our fiscal year 2020 annual goodwill and indefinite-lived intangible asset impairment test was performed during the three months ended September 30, 2020. We determined no goodwill impairment existed and that the fair value was substantially in excess of the carrying value. Additionally, no indefinite-lived asset impairment existed and the estimated fair values also substantially exceeded the carrying value for each of our indefinite-lived intangible assets.
Our intangible assets, other than goodwill, consist of the following:

| September 30, 2020 |  | December 31, 2019
(in Millions) | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net
Intangible assets subject to amortization (finite-lived)
Customer relationships | $ | 1,153.1 |  |  | $ | (230.9) |  |  | $ | 922.2 |  |  | $ | 1,139.7 |  |  | $ | (184.7) |  |  | $ | 955.0 |
Patents | 1.7 |  |  | (1.0) |  |  | 0.7 |  |  | 1.7 |  |  | (0.9) |  |  | 0.8 |
Brands (1) | 17.5 |  |  | (7.7) |  |  | 9.8 |  |  | 16.7 |  |  | (6.7) |  |  | 10.0 |
Purchased and licensed technologies | 61.0 |  |  | (37.3) |  |  | 23.7 |  |  | 60.2 |  |  | (35.2) |  |  | 25.0 |
Other intangibles | 3.4 |  |  | (3.0) |  |  | 0.4 |  |  | 1.9 |  |  | (1.8) |  |  | 0.1 |
| $ | 1,236.7 |  |  | $ | (279.9) |  |  | $ | 956.8 |  |  | $ | 1,220.2 |  |  | $ | (229.3) |  |  | $ | 990.9 |

Intangible assets not subject to amortization (indefinite-lived)
Crop Protection Brands (2) | $ | 1,259.1 |  |  |  |  | $ | 1,259.1 |  |  | $ | 1,259.1 |  |  |  |  | $ | 1,259.1 |
Brands (1) | 394.7 |  |  |  |  | 394.7 |  |  | 379.0 |  |  |  |  | 379.0 |
| $ | 1,653.8 |  |  |  |  | $ | 1,653.8 |  |  | $ | 1,638.1 |  |  |  |  | $ | 1,638.1 |
Total intangible assets | $ | 2,890.5 |  |  | $ | (279.9) |  |  | $ | 2,610.6 |  |  | $ | 2,858.3 |  |  | $ | (229.3) |  |  | $ | 2,629.0 |

____________________
(1) Represents trademarks, trade names and know-how.
(2) Represents proprietary brand portfolios, consisting of trademarks, trade names and know-how, of our crop protection brands.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Amortization expense | $ | 15.8 |  |  | $ | 16.1 |  |  | $ | 46.4 |  |  | $ | 47.2 |

The full year estimated pre-tax amortization expense for the year ended December 31, 2020 and each of the succeeding five years is approximately $63 million, $63 million, $63 million, $61 million, $61 million, and $61 million, respectively.
Note 7: Receivables
The following table displays a roll forward of the allowance for doubtful trade receivables.

(in Millions) |
Balance, December 31, 2018 | $ | 22.4 |
Additions - charged to expense | 3.6 |
Transfer from (to) allowance for credit losses (see below) | 3.4 |
Net recoveries, write-offs and other | (3.1) |
Balance, December 31, 2019 | $ | 26.3 |
Additions - charged to expense | 5.4 |
Transfer from (to) allowance for credit losses (see below) | (4.4) |
Net recoveries, write-offs and other | (4.8) |
Balance, September 30, 2020 | $ | 22.5 |

17

Table of Contents
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
We have non-current receivables that represent long-term customer receivable balances related to past due accounts which are not expected to be collected within the current year. The net long-term customer receivables were $109.6 million as of September 30, 2020. These long-term customer receivable balances and the corresponding allowance are included in "Other assets including long-term receivables, net" on the condensed consolidated balance sheets.
A portion of these long-term receivables have payment contracts. We have no reason to believe payments will not be made based upon the credit quality of these customers. Additionally, we also hold significant collateral against these customers including rights to property or other assets as a form of credit guarantee. If the customer does not pay or gives indication that they will not pay, these guarantees allow us to start legal action to block the sale of the customer’s harvest. On an ongoing basis, we continue to evaluate the credit quality of our non-current receivables using aging of receivables, collection experience and write-offs, as well as evaluating existing economic conditions, to determine if an additional allowance is necessary.
The following table displays a roll forward of the allowance for credit losses related to long-term customer receivables:

(in Millions) |
Balance, December 31, 2018 | $ | 60.5 |
Additions - charged to expense | 17.6 |
Transfer from (to) allowance for doubtful accounts (see above) | (3.4) |
Foreign currency adjustments | (0.5) |
Net recoveries, write-offs and other | (13.1) |
Balance, December 31, 2019 | $ | 61.1 |
Additions - charged to expense | (1.2) |
Transfer from (to) allowance for doubtful accounts (see above) | 4.4 |
Foreign currency adjustments | (8.8) |
Net recoveries, write-offs and other | (26.0) |
Balance, September 30, 2020 | $ | 29.5 |

Note 8: Inventories
Inventories consisted of the following:

(in Millions) | September 30, 2020 |  | December 31, 2019
Finished goods | $ | 190.2 |  |  | $ | 372.2 |
Work in process | 875.1 |  |  | 559.4 |
Raw materials, supplies and other | 223.2 |  |  | 217.3 |
First-in, first-out inventory | $ | 1,288.5 |  |  | $ | 1,148.9 |
Less: Excess of first-in, first-out cost over last-in, first-out cost | (133.0) |  |  | (131.9) |
Net inventories | $ | 1,155.5 |  |  | $ | 1,017.0 |

Note 9: Property, Plant and Equipment
Property, plant and equipment consisted of the following:

(in Millions) | September 30, 2020 |  | December 31, 2019
Property, plant and equipment | $ | 1,158.4 |  |  | $ | 1,109.2 |
Accumulated depreciation | (419.2) |  |  | (351.2) |
Property, plant and equipment, net | $ | 739.2 |  |  | $ | 758.0 |

18

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 10: Restructuring and Other Charges (Income)
Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income) as noted below.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Restructuring charges | $ | 6.9 |  |  | $ | 2.6 |  |  | $ | 29.7 |  |  | $ | 14.9 |
Other charges (income), net | 4.1 |  |  | 4.2 |  |  | 14.2 |  |  | 12.4 |
Total restructuring and other charges (income) | $ | 11.0 |  |  | $ | 6.8 |  |  | $ | 43.9 |  |  | $ | 27.3 |

Restructuring charges
For detail on restructuring activities which commenced prior to 2020, see Note 9 to our consolidated financial statements included within our 2019 Form 10-K.

(in Millions) | Severance and Employee Benefits |  | Other Charges (Income) (1) |  | Asset Disposal Charges (Income) (2) |  | Total
DuPont Crop restructuring | $ | 0.3 |  |  | $ | 2.1 |  |  | $ | 4.0 |  |  | $ | 6.4 |
Other items | 0.5 |  |  | — |  |  | — |  |  | 0.5 |
Three Months Ended September 30, 2020 | $ | 0.8 |  |  | $ | 2.1 |  |  | $ | 4.0 |  |  | $ | 6.9 |
DuPont Crop restructuring | $ | 0.9 |  |  | $ | 1.3 |  |  | $ | 0.4 |  |  | $ | 2.6 |
Other items | — |  |  | — |  |  | — |  |  | — |
Three Months Ended September 30, 2019 | $ | 0.9 |  |  | $ | 1.3 |  |  | $ | 0.4 |  |  | $ | 2.6 |
DuPont Crop restructuring | $ | 9.1 |  |  | $ | 3.4 |  |  | $ | 17.1 |  |  | $ | 29.6 |
Other items | 0.5 |  |  | — |  |  | (0.4) |  |  | 0.1 |
Nine Months Ended September 30, 2020 | $ | 9.6 |  |  | $ | 3.4 |  |  | $ | 16.7 |  |  | $ | 29.7 |
DuPont Crop restructuring | $ | 5.4 |  |  | $ | 3.3 |  |  | $ | 4.5 |  |  | $ | 13.2 |
Other items | 1.7 |  |  | — |  |  | — |  |  | 1.7 |
Nine Months Ended September 30, 2019 | $ | 7.1 |  |  | $ | 3.3 |  |  | $ | 4.5 |  |  | $ | 14.9 |

____________________
(1)Primarily represents third-party costs associated with miscellaneous restructuring activities. Other income, if applicable, primarily represents favorable developments on previously recorded exit costs and recoveries associated with restructuring.
(2)Primarily represents asset write-offs (recoveries) and accelerated depreciation on long-lived assets, which were or are to be abandoned. To the extent incurred, the acceleration effect of re-estimating settlement dates and revised cost estimates associated with asset retirement obligations due to facility shutdowns, are also included within the asset disposal charges.
As discussed in Note 5 "Acquisitions", we completed the integration of the DuPont Crop Protection Business except for the completion of certain in-flight initiatives including DuPont Crop restructuring. We anticipate remaining restructuring charges related to DuPont Crop restructuring of approximately $5 million to $10 million primarily associated with accelerated depreciation on certain fixed assets, severance, and other costs as we exit certain facilities.
19

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Roll forward of restructuring reserves
The following table shows a roll forward of restructuring reserves, continuing and discontinued, that will result in cash spending. These amounts exclude asset retirement obligations.

(in Millions) | Balance at 12/31/19 (3) |  | Change in reserves (4) |  | Cash payments (5) |  | Other |  | Balance at 9/30/20 (3)
DuPont Crop restructuring (1) | $ | 14.5 |  |  | $ | 12.5 |  |  | $ | (8.3) |  |  | $ | 0.3 |  |  | $ | 19.0 |
Other workforce related and facility shutdowns (2) | 0.1 |  |  | 0.5 |  |  | (0.2) |  |  | — |  |  | 0.4 |
Total | $ | 14.6 |  |  | $ | 13.0 |  |  | $ | (8.5) |  |  | $ | 0.3 |  |  | $ | 19.4 |

____________________
(1)Primarily consists of exit costs and severance associated with DuPont Crop restructuring activities.
(2)Primarily severance costs related to workforce reductions and facility shutdowns.
(3)Included in "Accrued and other liabilities" and "Other long-term liabilities" on the condensed consolidated balance sheets.
(4)Primarily severance, exited lease, contract termination and other miscellaneous exit costs. Any accelerated depreciation and impairment charges noted above that impacted our property, plant and equipment balances or other long-term assets are not included in this table.
(5)In addition to the spend above there was also $3.1 million of spending related to the Furadan® asset retirement obligation.
Other charges (income), net

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Environmental charges, net | $ | 4.0 |  |  | $ | 4.1 |  |  | $ | 13.7 |  |  | $ | 12.3 |
Product portfolio sales | — |  |  | 0.1 |  |  | — |  |  | 0.1 |
Other items, net | 0.1 |  |  | — |  |  | 0.5 |  |  | — |
Other charges (income), net | $ | 4.1 |  |  | $ | 4.2 |  |  | $ | 14.2 |  |  | $ | 12.4 |

Environmental charges, net
Environmental charges represent the net charges associated with environmental remediation at continuing operating sites. See Note 13 for additional details. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.
Note 11: Debt
Debt maturing within one year:

(in Millions) | September 30, 2020 |  | December 31, 2019
Short-term foreign debt (1) | $ | 116.2 |  |  | $ | 144.9 |
Commercial paper (2) | — |  |  | — |
Total short-term debt | $ | 116.2 |  |  | $ | 144.9 |
Current portion of long-term debt | 77.9 |  |  | 82.8 |
Total short-term debt and current portion of long-term debt | $ | 194.1 |  |  | $ | 227.7 |

____________________
(1) At September 30, 2020, the average effective interest rate on the borrowings was 12.8 percent.
(2) We had no borrowings outstanding under our commercial paper program in either period.
20

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Long-term debt:

(in Millions) | September 30, 2020 |  |  |  |
Interest Rate Percentage |  | Maturity Date |  | September 30, 2020 |  | December 31, 2019
Pollution control and industrial revenue bonds (less unamortized discounts of $0.1 and $0.2, respectively) | 0.3% - 6.5% |  | 2021 - 2032 |  | $ | 51.7 |  |  | $ | 51.6 |
Senior notes (less unamortized discount of $1.1 and $1.3, respectively) | 3.2% - 4.5% |  | 2022 - 2049 |  | 2,198.9 |  |  | 2,198.7 |
2017 Term Loan Facility | 1.4% |  | 2022 |  | 800.0 |  |  | 800.0 |
Revolving Credit Facility (1) | 2.8% |  | 2024 |  | — |  |  | — |
Foreign debt | 0% - 6.1% |  | 2021 - 2024 |  | 76.4 |  |  | 83.8 |
Debt issuance cost |  |  |  |  | (20.8) |  |  | (20.2) |
Total long-term debt |  |  |  |  | $ | 3,106.2 |  |  | $ | 3,113.9 |
Less: debt maturing within one year |  |  |  |  | 77.9 |  |  | 82.8 |
Total long-term debt, less current portion |  |  |  |  | $ | 3,028.3 |  |  | $ | 3,031.1 |

____________________
(1)Letters of credit outstanding under our Revolving Credit Facility totaled $215.2 million and available funds under this facility were $1,284.8 million at September 30, 2020.
Revolving Credit Facility Agreement Amendment
On April 22, 2020, the Company entered into Amendment No. 1 (the "Revolving Credit Amendment") to the Third Amended and Restated Credit Agreement, dated as of May 17, 2019, among the Company, as U.S. Borrower, certain foreign subsidiaries of the Company party thereto, as Euro Borrowers, the lenders (the "Revolving Credit Lenders") and issuing banks party thereto, Citibank, N.A., as administrative agent, Citibank, N.A. and BofA Securities, Inc., as joint lead arrangers, Bank of America, N.A., as syndication agent, and certain other financial institutions party thereto as co-documentation agents (the "Revolving Credit Agreement"). Among other things, the Revolving Credit Amendment amends the maximum leverage ratio financial covenant in the Revolving Credit Agreement and adds a negative covenant restricting purchases of the Company’s stock if at any time the maximum leverage ratio exceeds 3.5 through the period ending June 30, 2021.
2017 Term Loan Agreement Amendment
On April 22, 2020, the Company entered into Amendment No. 2 (the "Term Loan Amendment") to the Term Loan Agreement, dated as of May 2, 2017, among the Company, as U.S. Borrower, certain foreign subsidiaries of the Company party thereto, as Euro Borrowers, the lenders party thereto (the "Term Loan Lenders"), Citibank, N.A., as administrative agent, Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers, Bank of America, N.A., as syndication agent, and certain other financial institutions party thereto as co-documentation agents (as previously amended, the "Term Loan Agreement"). Among other things, the Term Loan Amendment amends the maximum leverage ratio financial covenant in the Term Loan Agreement and adds a negative covenant restricting purchases of the Company’s stock if at any time the maximum leverage ratio exceeds 3.5 through the period ending June 30, 2021.
Deferred financing fees totaling $3.5 million associated with both amendments have been deferred and is being recognized to interest expense over the life of the agreements.
Covenants
Among other restrictions, our Revolving Credit Facility and 2017 Term Loan Facility contain financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended September 30, 2020 was 2.8, which is below the maximum leverage of 4.25 at September 30, 2020. As amended pursuant to the Revolving Credit Amendment and the Term Loan Amendment discussed above, the maximum leverage ratio has been increased to 4.25 through the period ending December 31, 2020. The maximum leverage ratio will step down to 4.0 for the quarter ending March 31, 2021 and then to 3.5 for future quarters. Our actual interest coverage for the four consecutive quarters ended September 30, 2020 was 7.9, which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at September 30, 2020.
21

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 12: Discontinued Operations
FMC Lithium (Livent Corporation):
On March 1, 2019, we completed the previously announced distribution of 123 million shares of common stock of Livent as a pro rata dividend on shares of FMC common stock outstanding at the close of business on the record date of February 25, 2019.
The results of our discontinued FMC Lithium operations are summarized below:

(in Millions) | Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
Revenue | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 52.1 |
Costs of sales and services | — |  |  | — |  |  | — |  |  | 41.3 |
Income (loss) from discontinued operations before income taxes | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1.1 |
Provision (benefit) for income taxes | — |  |  | — |  |  | — |  |  | 6.0 |
Total discontinued operations of FMC Lithium, net of income taxes, before separation-related costs and other adjustments | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4.9) |
Separation-related costs and other adjustments of discontinued operations of FMC Lithium, net of income taxes | — |  |  | 0.1 |  |  | 1.0 |  |  | (13.6) |
Discontinued operations of FMC Lithium, net of income taxes | $ | — |  |  | $ | 0.1 |  |  | $ | 1.0 |  |  | $ | (18.5) |

Discontinued operations include the results of FMC Lithium and adjustments to retained assets and liabilities as well as provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations and retained liabilities. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Our discontinued operations comprised the following:

(in Millions) | Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
Adjustment for workers’ compensation, product liability, other postretirement benefits and other, net of income tax benefit (expense) of $(2.9) and $(4.9) for the three and nine months ended September 30, 2020 and $(5.1) and $(12.7) for the three and nine months ended September 30, 2019, respectively (1) | $ | (3.9) |  |  | $ | (7.6) |  |  | $ | (2.7) |  |  | $ | 14.4 |
Provision for environmental liabilities, net of recoveries, net of income tax benefit of $2.1 and $3.3 for the three and nine months ended September 30, 2020 and $1.8 and $2.6 for the three and nine months ended September 30, 2019, respectively | (8.8) |  |  | (6.2) |  |  | (13.3) |  |  | (9.1) |
Provision for legal reserves and expenses, net of recoveries, net of income tax benefit of $1.5 and $5.8 for the three and nine months ended September 30, 2020 and $2.0 and $4.4 for the three and nine months ended September 30, 2019, respectively | (5.7) |  |  | (7.6) |  |  | (21.7) |  |  | (16.6) |
Discontinued operations of FMC Lithium, net of income tax benefit (expense) of zero and $(0.1) for the three and nine months ended September 30, 2020 and zero and $(9.7) for the three and nine months ended September 30, 2019, respectively | — |  |  | 0.1 |  |  | 1.0 |  |  | (18.5) |
Discontinued operations, net of income taxes | $ | (18.4) |  |  | $ | (21.3) |  |  | $ | (36.7) |  |  | $ | (29.8) |

____________________
(1)During the nine months ended September 30, 2019, we finalized the sale of the first of two parcels of land of our discontinued site in Newark, California and recorded a gain of approximately $21 million, net of tax.
22

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 13: Environmental Obligations
We have reserves for potential environmental obligations which we consider probable and which we can reasonably estimate. The following table is a roll forward of our total environmental reserves, continuing and discontinued:

(in Millions) | Gross |  | Recoveries (3) |  | Net
Total environmental reserves at December 31, 2019 | $ | 595.8 |  |  | $ | (10.0) |  |  | $ | 585.8 |
Provision (Benefit) | 28.8 |  |  | (0.9) |  |  | 27.9 |
(Spending) Recoveries | (57.7) |  |  | 0.6 |  |  | (57.1) |
Foreign currency translation adjustments | 3.0 |  |  | — |  |  | 3.0 |
Net change | $ | (25.9) |  |  | $ | (0.3) |  |  | $ | (26.2) |
Total environmental reserves at September 30, 2020 | $ | 569.9 |  |  | $ | (10.3) |  |  | $ | 559.6 |
Environmental reserves, current (1) | $ | 136.7 |  |  | $ | (1.5) |  |  | $ | 135.2 |
Environmental reserves, long-term (2) | 433.2 |  |  | (8.8) |  |  | 424.4 |
Total environmental reserves at September 30, 2020 | $ | 569.9 |  |  | $ | (10.3) |  |  | $ | 559.6 |

____________________
(1)These amounts are included within "Accrued and other liabilities" on the condensed consolidated balance sheets.
(2)These amounts are included in "Environmental liabilities, continuing and discontinued" on the condensed consolidated balance sheets.
(3)These recorded recoveries represent probable realization of claims against U.S. government agencies and are recorded as an offset to our environmental reserves in the condensed consolidated balance sheets.
The estimated reasonably possible environmental loss contingencies, net of expected recoveries, exceed amounts accrued by approximately $160 million at September 30, 2020. This reasonably possible estimate is based upon information available as of the date of the filing but the actual future losses may be higher given the uncertainties regarding the status of laws, regulations, enforcement policies, the impact of potentially responsible parties, technology and information related to individual sites. Potential environmental obligations that have not been reserved may be material to any one quarter's or year's results of operations in the future. However, we believe any such liability arising from such potential environmental obligations is not likely to have a material adverse effect on our liquidity or financial condition as it may be satisfied over many years.
The table below provides a roll forward of our environmental recoveries representing probable realization of claims against insurance carriers and other third parties. These recoveries are recorded as "Other assets including long-term receivables, net" in the condensed consolidated balance sheets.

(in Millions) | December 31, 2019 |  | Increase (Decrease) in recoveries |  | Cash received (1) |  |  |  | September 30, 2020
Environmental recoveries | $ | 27.3 |  |  | (2.4) |  |  | (20.4) |  |  |  |  | $ | 4.5 |

____________________
(1) During the first quarter of 2020, we entered into a confidential insurance settlement pertaining to coverage at a legacy environmental site, which settlement resulted in a cash payment to FMC in the amount of $20.0 million.
23

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Our net environmental provisions relate to costs for the continued cleanup of both continuing and discontinued manufacturing operations from previous years. The net provisions are comprised as follows:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Environmental provisions, net - recorded to liabilities (1) | $ | 15.9 |  |  | $ | 12.0 |  |  | $ | 27.9 |  |  | $ | 24.5 |
Environmental provisions, net - recorded to assets (2) | (1.0) |  |  | 0.1 |  |  | 2.4 |  |  | (0.5) |
Environmental provision, net | $ | 14.9 |  |  | $ | 12.1 |  |  | $ | 30.3 |  |  | $ | 24.0 |
Continuing operations (3) | $ | 4.0 |  |  | $ | 4.1 |  |  | $ | 13.7 |  |  | $ | 12.3 |
Discontinued operations (4) | 10.9 |  |  | 8.0 |  |  | 16.6 |  |  | 11.7 |
Environmental provision, net | $ | 14.9 |  |  | $ | 12.1 |  |  | $ | 30.3 |  |  | $ | 24.0 |

____________________
(1) See above roll forward of our total environmental reserves as presented on the condensed consolidated balance sheets.
(2) See above roll forward of our total environmental recoveries as presented on the condensed consolidated balance sheets.
(3) Recorded as a component of "Restructuring and other charges (income)" on the condensed consolidated statements of income (loss). See Note 10. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations.
(4) Recorded as a component of "Discontinued operations, net of income taxes" on the condensed consolidated statements of income (loss). See Note 12.
A more complete description of our environmental contingencies and the nature of our potential obligations are included in Notes 1 and 12 to our consolidated financial statements in our 2019 Form 10-K. See Note 12 to our consolidated financial statements in our 2019 Form 10-K for a description of significant updates to material environmental sites. There have been no significant updates since the information included in our 2019 Form 10-K other than the updates provided below.
Pocatello Tribal Litigation
On March 16, 2020, FMC filed a petition in the United States Supreme Court to review the Ninth Circuit’s decision. On June 29, 2020 the Supreme Court invited the Solicitor General to file a brief in this case expressing the views of the United States with respect to the litigation. As of the filing of this Form 10-Q, the Solicitor General has not filed its brief and the Supreme Court has not made a decision on whether or not to grant FMC’s petition for writ of certiorari. Payment of the judgment, if necessary, will not take place until final disposition by the United States Supreme Court. There was no change to our existing reserves as a result of the most recent events.
Middleport
On September 30, 2020, the New York State Department of Environmental Conservation ("NYSDEC") issued a draft Statement of Basis proposing a remedy for seven undeveloped/wooded parcels of land referred to as "Air Deposition Area #2" or "OU 3". FMC previously submitted a Corrective Measures Study ("CMS") for OU 3 in 2015 and based on the current land use and arsenic concentrations, recommended no further action. FMC has evaluated the proposed remedy and we have increased the reserve by $6.6 million to reflect our best estimate for the cost of remediating OU 3. As a result, we increased our reasonably possible loss estimate for Middleport to reflect the potential cost of remediation in excess of our reserves.
Note 14: Earnings Per Share
Earnings per common share ("EPS") is computed by dividing net income by the weighted average number of common shares outstanding during the period on a basic and diluted basis.
Our potentially dilutive securities include potential common shares related to our stock options, restricted stock and restricted stock units. Diluted earnings per share ("Diluted EPS") considers the impact of potentially dilutive securities except in periods in which there is a loss from continuing operations because the inclusion of the potential common shares would have an antidilutive effect. Diluted EPS excludes the impact of potential common shares related to our stock options in periods in which the option exercise price is greater than the average market price of our common stock for the period. For the three and nine months ended September 30, 2020, there were 0.2 million and 0.3 million potential common shares excluded from Diluted EPS,
24

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
respectively. For the three and nine months ended September 30, 2019, there were 0.4 million and 0.4 million potential common shares excluded from Diluted EPS, respectively.
Our non-vested restricted stock awards contain rights to receive non-forfeitable dividends, and thus, are participating securities requiring the two-class method of computing EPS. The two-class method determines EPS by dividing the sum of distributed earnings to common stockholders and undistributed earnings allocated to common stockholders by the weighted average number of shares of common stock outstanding for the period. In calculating the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the weighted average number of shares outstanding during the period.
Earnings applicable to common stock and common stock shares used in the calculation of basic and diluted earnings per share are as follows:

(in Millions, Except Share and Per Share Data) | Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
Earnings (loss) attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations, net of income taxes | $ | 129.8 |  |  | $ | 111.7 |  |  | $ | 538.7 |  |  | $ | 510.4 |
Discontinued operations, net of income taxes | (18.4) |  |  | (21.3) |  |  | (36.7) |  |  | (29.8) |
Net income (loss) attributable to FMC stockholders | $ | 111.4 |  |  | $ | 90.4 |  |  | $ | 502.0 |  |  | $ | 480.6 |
Less: Distributed and undistributed earnings allocable to restricted award holders | (0.3) |  |  | (0.3) |  |  | (1.3) |  |  | (1.5) |
Net income (loss) allocable to common stockholders | $ | 111.1 |  |  | $ | 90.1 |  |  | $ | 500.7 |  |  | $ | 479.1 |
Basic earnings (loss) per common share attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.00 |  |  | $ | 0.85 |  |  | $ | 4.14 |  |  | $ | 3.88 |
Discontinued operations | (0.14) |  |  | (0.16) |  |  | (0.28) |  |  | (0.22) |
Net income (loss) attributable to FMC stockholders | $ | 0.86 |  |  | $ | 0.69 |  |  | $ | 3.86 |  |  | $ | 3.66 |
Diluted earnings (loss) per common share attributable to FMC stockholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.99 |  |  | $ | 0.85 |  |  | $ | 4.12 |  |  | $ | 3.85 |
Discontinued operations | (0.14) |  |  | (0.16) |  |  | (0.28) |  |  | (0.22) |
Net income (loss) attributable to FMC stockholders | $ | 0.85 |  |  | $ | 0.69 |  |  | $ | 3.84 |  |  | $ | 3.63 |
Shares (in thousands): |  |  |  |  |  |  |
Weighted average number of shares of common stock outstanding - Basic | 129,888 |  |  | 130,390 |  |  | 129,710 |  |  | 131,106 |
Weighted average additional shares assuming conversion of potential common shares | 911 |  |  | 1,210 |  |  | 886 |  |  | 1,254 |
Shares – diluted basis | 130,799 |  |  | 131,600 |  |  | 130,596 |  |  | 132,360 |

25

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 15: Equity
Accumulated other comprehensive income (loss)
Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.

(in Millions) | Foreign currency adjustments |  | Derivative Instruments (1) |  | Pension and other postretirement benefits (2) |  | Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2019 | $ | (77.7) |  |  | $ | (65.0) |  |  | $ | (269.3) |  |  | $ | (412.0) |
2020 Activity |  |  |  |  |  |  |
Other comprehensive income (loss) before reclassifications | 28.2 |  |  | 29.3 |  |  | — |  |  | 57.5 |
Amounts reclassified from accumulated other comprehensive income (loss) | — |  |  | (15.4) |  |  | 12.0 |  |  | (3.4) |
Net current period other comprehensive income (loss) | $ | 28.2 |  |  | $ | 13.9 |  |  | $ | 12.0 |  |  | $ | 54.1 |
Accumulated other comprehensive income (loss), net of tax at September 30, 2020 | $ | (49.5) |  |  | $ | (51.1) |  |  | $ | (257.3) |  |  | $ | (357.9) |

(in Millions) | Foreign currency adjustments |  | Derivative Instruments (1) |  | Pension and other postretirement benefits (2) |  | Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2018 | $ | (101.5) |  |  | $ | 11.2 |  |  | $ | (218.6) |  |  | $ | (308.9) |
2019 Activity |  |  |  |  |  |  |
Other comprehensive income (loss) before reclassifications | (40.8) |  |  | (62.0) |  |  | — |  |  | (102.8) |
Amounts reclassified from accumulated other comprehensive income (loss) | — |  |  | (8.0) |  |  | 7.0 |  |  | (1.0) |
Net current period other comprehensive income (loss) | $ | (40.8) |  |  | $ | (70.0) |  |  | $ | 7.0 |  |  | $ | (103.8) |
Adoption of accounting standard | — |  |  | 1.0 |  |  | (54.1) |  |  | (53.1) |
Distribution of FMC Lithium (3) | 39.0 |  |  | — |  |  | — |  |  | 39.0 |
Accumulated other comprehensive income (loss), net of tax at September 30, 2019 | $ | (103.3) |  |  | $ | (57.8) |  |  | $ | (265.7) |  |  | $ | (426.8) |

____________________
(1) See Note 18 for more information.
(2) See Note 16 for more information.
(3) Represents the effects of the distribution of FMC Lithium.
26

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Reclassifications of accumulated other comprehensive income (loss)
The table below provides details about the reclassifications from accumulated other comprehensive income (loss) and the affected line items in the condensed consolidated statements of income (loss) for each of the periods presented:

Details about Accumulated Other Comprehensive Income Components | Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (1) | Affected Line Item in the Condensed Consolidated Statements of Income (Loss)
| Three Months Ended September 30, |  | Nine Months Ended September 30, |
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019 |
Derivative instruments |  |  |  |  |  |  |  |
Foreign currency contracts | $ | (2.5) |  |  | $ | 1.5 |  |  | $ | 28.3 |  |  | $ | 8.4 |  | Costs of sales and services
Foreign currency contracts | (5.3) |  |  | 0.5 |  |  | (14.0) |  |  | 2.2 |  | Selling, general and administrative expenses
Interest rate contracts | 1.1 |  |  | (0.2) |  |  | 1.6 |  |  | (0.3) |  | Interest expense, net
Total before tax | $ | (6.7) |  |  | $ | 1.8 |  |  | $ | 15.9 |  |  | $ | 10.3 |  |
| 3.4 |  |  | (0.6) |  |  | (0.5) |  |  | (2.3) |  | Provision for income taxes
Amount included in net income (loss) | $ | (3.3) |  |  | $ | 1.2 |  |  | $ | 15.4 |  |  | $ | 8.0 |  |
Pension and other postretirement benefits (2) |  |  |  |  |  |  |  |
Amortization of prior service costs | $ | (0.1) |  |  | $ | (0.2) |  |  | $ | (0.2) |  |  | $ | (0.3) |  | Selling, general and administrative expenses
Amortization of unrecognized net actuarial and other gains (losses) | (10.4) |  |  | 0.3 |  |  | (14.4) |  |  | (8.1) |  | Selling, general and administrative expenses
Recognized loss due to curtailment and settlement | (0.6) |  |  | (0.5) |  |  | (0.6) |  |  | (0.5) |  | Selling, general and administrative expenses
Total before tax | $ | (11.1) |  |  | $ | (0.4) |  |  | $ | (15.2) |  |  | $ | (8.9) |  |
| 2.3 |  |  | 0.1 |  |  | 3.2 |  |  | 1.9 |  | Provision for income taxes
Amount included in net income (loss) | $ | (8.8) |  |  | $ | (0.3) |  |  | $ | (12.0) |  |  | $ | (7.0) |  |
Total reclassifications for the period | $ | (12.1) |  |  | $ | 0.9 |  |  | $ | 3.4 |  |  | $ | 1.0 |  | Amount included in net income

____________________
(1)Amounts in parentheses indicate charges to the condensed consolidated statements of income (loss).
(2)Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 16.
Dividends and Share Repurchases
During the nine months ended September 30, 2020 and September 30, 2019, we paid dividends of $171.3 million and $158.3 million, respectively. On October 15, 2020, we paid dividends totaling $57.2 million to our shareholders of record as of September 30, 2020. This amount is included in "Accrued and other liabilities" on the condensed consolidated balance sheet as of September 30, 2020.
During the nine months ended September 30, 2020, no shares were repurchased under the publicly announced repurchase program. At September 30, 2020, approximately $600 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.
27

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 16: Pensions and Other Postretirement Benefits
The following table summarizes the components of net annual benefit cost (income):

(in Millions) | Three Months Ended September 30, |  | Nine Months Ended September 30,
Pensions |  | Other Benefits |  | Pensions |  | Other Benefits
2020 |  | 2019 |  | 2020 |  | 2019 |  | 2020 |  | 2019 |  | 2020 |  | 2019
Service cost | $ | 1.4 |  |  | $ | (0.1) |  |  | $ | — |  |  | $ | — |  |  | $ | 3.6 |  |  | $ | 2.4 |  |  | $ | — |  |  | $ | — |
Interest cost | 9.3 |  |  | 11.4 |  |  | 0.1 |  |  | 0.1 |  |  | 27.6 |  |  | 35.7 |  |  | 0.3 |  |  | 0.5 |
Expected return on plan assets | (9.2) |  |  | (13.3) |  |  | — |  |  | — |  |  | (27.8) |  |  | (40.1) |  |  | — |  |  | — |
Amortization of prior service cost (credit) | — |  |  | 0.1 |  |  | — |  |  | 0.1 |  |  | 0.1 |  |  | 0.2 |  |  | — |  |  | 0.1 |
Recognized net actuarial and other (gain) loss | 11.1 |  |  | 0.5 |  |  | (0.3) |  |  | (0.4) |  |  | 16.0 |  |  | 9.7 |  |  | (0.7) |  |  | (0.8) |
Recognized loss due to settlement (1) | 0.6 |  |  | 0.5 |  |  | — |  |  | — |  |  | 0.6 |  |  | 0.5 |  |  | — |  |  | — |
Net periodic benefit cost (income) | $ | 13.2 |  |  | $ | (0.9) |  |  | $ | (0.2) |  |  | $ | (0.2) |  |  | $ | 20.1 |  |  | $ | 8.4 |  |  | $ | (0.4) |  |  | $ | (0.2) |

___________________
(1)Settlement charge relates to the U.S. nonqualified defined benefit pension plan.
We made voluntary cash contributions to our U.S. qualified defined benefit pension plan in the nine months ended September 30, 2020 and 2019 of zero and $7.0 million, respectively. We do not expect to make any contributions to our U.S. qualified defined benefit pension plan during 2020.
Note 17: Income Taxes
We determine our interim tax provision using an Estimated Annual Effective Tax Rate methodology ("EAETR") in accordance with U.S. GAAP. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision.
The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income in each tax jurisdiction in which we operate. As our projections of ordinary income change throughout the year, the EAETR will change period-to-period. The tax effects of discrete items are recognized in the tax provision in the period they occur in accordance with U.S. GAAP. Depending on various factors, such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. As a global enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews, as well as other factors. As a result, there can be significant volatility in interim tax provisions.
The below chart provides a reconciliation between our reported effective tax rate and the EAETR of our continuing operations:

| Three Months Ended September 30,
| 2020 |  | 2019
(in Millions) | Before Tax | Tax | Effective Tax Rate % |  | Before Tax | Tax | Effective Tax Rate %
Continuing operations | $ | 148.9 |  | $ | 18.4 |  | 12.4 | % |  | $ | 119.5 |  | $ | 8.7 |  | 7.3 | %
Discrete items: |  |  |  |  |  |  |
Currency remeasurement (1) | $ | 3.8 |  | $ | 0.5 |  |  |  | $ | (6.3) |  | $ | — |  |
Other discrete items (2) | 77.2 |  | 3.1 |  |  |  | 29.2 |  | (1.9) |  |
Tax only discrete items (3) | — |  | 4.4 |  |  |  | — |  | 6.9 |  |
Total discrete items | $ | 81.0 |  | $ | 8.0 |  |  |  | $ | 22.9 |  | $ | 5.0 |  |
Continuing operations, before discrete items | $ | 229.9 |  | $ | 26.4 |  |  |  | $ | 142.4 |  | $ | 13.7 |  |
Estimated Annualized Effective Tax Rate (EAETR) |  |  | 11.5 | % |  |  |  | 9.6 | %

28

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)

| Nine Months Ended September 30,
| 2020 |  | 2019
(in Millions) | Before Tax | Tax | Effective Tax Rate % |  | Before Tax | Tax | Effective Tax Rate %
Continuing operations | $ | 622.3 |  | $ | 82.3 |  | 13.2 | % |  | $ | 588.4 |  | $ | 75.6 |  | 12.8 | %
Discrete items: |  |  |  |  |  |  |
Currency remeasurement (1) | $ | 9.8 |  | $ | (1.9) |  |  |  | $ | 2.0 |  | $ | 2.8 |  |
Other discrete items (2) | 212.7 |  | 11.6 |  |  |  | 122.2 |  | 6.0 |  |
Tax only discrete items (3) | — |  | 15.8 |  |  |  | — |  | 9.2 |  |
Total discrete items | $ | 222.5 |  | $ | 25.5 |  |  |  | $ | 124.2 |  | $ | 18.0 |  |
Continuing operations, before discrete items | $ | 844.8 |  | $ | 107.8 |  |  |  | $ | 712.6 |  | $ | 93.6 |  |
Estimated Annualized Effective Tax Rate (EAETR) |  |  | 12.8 | % |  |  |  | 13.1 | %

___________________
(1)Represents transaction gains or losses for currency remeasurement offset by associated hedge gains or losses, which are accounted for discretely in accordance with U.S. GAAP. Certain transaction gains or losses for currency remeasurement are not taxable, while offsetting hedge gains or losses are taxable.
(2)U.S. GAAP generally requires subsidiaries for which a full valuation allowance has been provided to be excluded from the EAETR. For the three and nine months ended September 30, 2020 and 2019, other discrete items were materially comprised of the accounting for excluded pretax losses of subsidiaries for which a full valuation allowance has been provided.
(3)For the three and nine months ended September 30, 2020 and 2019, tax only discrete items are primarily comprised of the tax effect of currency remeasurement associated with foreign statutory operations, excess tax benefits associated with share-based compensation, changes in uncertain tax liabilities and related interest, and changes in tax law.
Note 18: Financial Instruments, Risk Management and Fair Value Measurements
Our financial instruments include cash and cash equivalents, trade receivables, other current assets, certain receivables classified as other long-term assets, accounts payable, and amounts included in investments and accruals meeting the definition of financial instruments. The carrying value of these financial instruments approximates their fair value. Our other financial instruments include the following:

Financial Instrument |  | Valuation Method
Foreign exchange forward contracts |  | Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.
Commodity forward contracts |  | Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices for applicable commodities.
Debt |  | Our estimates and information obtained from independent third parties using market data, such as bid/ask spreads for the last business day of the reporting period.

The estimated fair value of the financial instruments in the above table have been determined using standard pricing models which take into account the present value of expected future cash flows discounted to the balance sheet date. These standard pricing models utilize inputs derived from or corroborated by observable market data such as interest rate yield curves and currency and commodity spot and forward rates. In addition, we test a subset of our valuations against valuations received from the transaction's counterparty to validate the accuracy of our standard pricing models. Accordingly, the estimates presented may not be indicative of the amounts that we would realize in a market exchange at settlement date and do not represent potential gains or losses on these agreements. The estimated fair values of foreign exchange forward contracts and commodity forward contracts are included in the tables within this Note. The estimated fair value of debt is $3,554.2 million and $3,393.8 million and the carrying amount is $3,222.4 million and $3,258.8 million as of September 30, 2020 and December 31, 2019, respectively.
We enter into various financial instruments with off-balance sheet risk as part of the normal course of business. These off-balance sheet instruments include financial guarantees and contractual commitments to extend financial guarantees under letters of credit, and other assistance to customers. See Note 19 for more information. Decisions to extend financial guarantees to
29

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
customers and the amount of collateral required under these guarantees are based on our evaluation of creditworthiness on a case-by-case basis.
Use of Derivative Financial Instruments to Manage Risk
We mitigate certain financial exposures, including currency risk, commodity purchase exposures and interest rate risk, through a program of risk management that includes the use of derivative financial instruments. We enter into derivative contracts, including forward contracts and purchased options, to reduce the effects of fluctuating currency exchange rates, interest rates, and commodity prices. A detailed description of these risks including a discussion on the concentration of credit risk is provided in Note 19 to our consolidated financial statements on our 2019 Form 10-K.
We formally document all relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also assess, both at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If we determine that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we discontinue hedge accounting with respect to that derivative prospectively.
Accounting for Derivative Instruments and Hedging Activities
Cash Flow Hedges
We recognize all derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, we generally designate the derivative as a hedge of the variability of cash flows to be received or paid related to a forecasted transaction (cash flow hedge). We record in AOCI changes in the fair value of derivatives that are designated as and meet all the required criteria for a cash flow hedge. We then reclassify these amounts into earnings as the underlying hedged item affects earnings. In contrast, we immediately record in earnings changes in the fair value of derivatives that are not designated as cash flow hedges.
As of September 30, 2020, we had open foreign currency forward and option contracts in AOCI in a net after tax gain position of $11.8 million designated as cash flow hedges of underlying forecasted sales and purchases. Current open contracts hedge forecasted transactions until December 31, 2020. At September 30, 2020, we had open forward and option contracts designated as cash flow hedges with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $1,218 million.
As of September 30, 2020, we had open interest rate contracts in AOCI in a net after tax loss position of $2.7 million designated as cash flow hedges of the anticipated fixed rate coupon of debt forecasted to be issued within a designated window. At September 30, 2020, we had interest rate swap contracts outstanding with a total aggregate notional value of approximately $100 million.
In conjunction with the issuance of the Senior Notes, on September 20, 2019 we settled on various interest rate swap agreements which were entered into to hedge the variability in treasury rates. This settlement resulted in a loss of $83.1 million which was recorded in other comprehensive income and will be amortized over the various terms of the Senior Notes.
As of September 30, 2020, we had no open commodity contracts in AOCI designated as cash flow hedges of underlying forecasted purchases. At September 30, 2020, we had zero mmBTUs (millions of British Thermal Units) in aggregate notional volume of outstanding natural gas commodity forward contracts to hedge forecasted purchases.
Approximately $10.3 million of the net gains after-tax, representing open foreign currency exchange and option contracts and interest rate contracts, will be realized in earnings during the twelve months ending September 30, 2021 if spot rates in the future are consistent with forward rates as of September 30, 2020. The actual effect on earnings will be dependent on the actual spot rates when the forecasted transactions occur.
Derivatives Not Designated As Hedging Instruments
We hold certain forward contracts that have not been designated as cash flow hedging instruments for accounting purposes. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as cash flow hedging instruments, and changes in the fair value of these items are recorded in earnings.
We had open forward contracts not designated as cash flow hedging instruments for accounting purposes with various expiration dates to buy, sell or exchange foreign currencies with a U.S. dollar equivalent of approximately $1,834 million at September 30, 2020.
30

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Fair Value of Derivative Instruments
The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments.

| September 30, 2020
| Gross Amount of Derivatives |  |  |  |  |  |
(in Millions) | Designated as Cash Flow Hedges |  | Not Designated as Hedging Instruments |  | Total Gross Amounts |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheet (3) |  | Net Amounts
Foreign exchange contracts | $ | 26.5 |  |  | $ | 4.5 |  |  | $ | 31.0 |  |  | $ | (11.9) |  |  | $ | 19.1 |
Total derivative assets (1) | $ | 26.5 |  |  | $ | 4.5 |  |  | $ | 31.0 |  |  | $ | (11.9) |  |  | $ | 19.1 |
Foreign exchange contracts | $ | (16.8) |  |  | $ | (0.5) |  |  | $ | (17.3) |  |  | $ | 11.9 |  |  | $ | (5.4) |
Interest rate contracts | (3.4) |  |  | — |  |  | (3.4) |  |  | — |  |  | (3.4) |
Total derivative liabilities (2) | $ | (20.2) |  |  | $ | (0.5) |  |  | $ | (20.7) |  |  | $ | 11.9 |  |  | $ | (8.8) |
Net derivative assets (liabilities) | $ | 6.3 |  |  | $ | 4.0 |  |  | $ | 10.3 |  |  | $ | — |  |  | $ | 10.3 |

| December 31, 2019
| Gross Amount of Derivatives |  |
(in Millions) | Designated as Cash Flow Hedges |  | Not Designated as Hedging Instruments |  | Total Gross Amounts |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheet (3) |  | Net Amounts
Foreign exchange contracts | $ | 8.0 |  |  | $ | 0.3 |  |  | $ | 8.3 |  |  | $ | (8.1) |  |  | $ | 0.2 |
Total derivative assets (1) | $ | 8.0 |  |  | $ | 0.3 |  |  | $ | 8.3 |  |  | $ | (8.1) |  |  | $ | 0.2 |
Foreign exchange contracts | $ | (12.1) |  |  | $ | (4.2) |  |  | $ | (16.3) |  |  | $ | 8.1 |  |  | $ | (8.2) |
Interest rate contracts | (0.9) |  |  | — |  |  | (0.9) |  |  | — |  |  | (0.9) |
Total derivative liabilities (2) | $ | (13.0) |  |  | $ | (4.2) |  |  | $ | (17.2) |  |  | $ | 8.1 |  |  | $ | (9.1) |
Net derivative assets (liabilities) | $ | (5.0) |  |  | $ | (3.9) |  |  | $ | (8.9) |  |  | $ | — |  |  | $ | (8.9) |

____________________
(1) Net balance is included in "Prepaid and other current assets" in the condensed consolidated balance sheets.
(2) Net balance is included in "Accrued and other liabilities" in the condensed consolidated balance sheets.
(3) Represents net derivatives positions subject to master netting arrangements.
31

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
The tables below summarize the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments.
Derivatives in Cash Flow Hedging Relationships

| Contracts |  |
| Foreign Exchange |  |  |  | Interest rate |  | Total
| Three Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  |  |  |  |  | 2020 |  | 2019 |  | 2020 |  | 2019
Unrealized hedging gains (losses) and other, net of tax | $ | 1.4 |  |  | $ | 8.4 |  |  |  |  |  |  | $ | 2.5 |  |  | $ | (33.9) |  |  | $ | 3.9 |  |  | $ | (25.5) |
Reclassification of deferred hedging (gains) losses, net of tax (1) | 4.1 |  |  | (1.4) |  |  |  |  |  |  | (0.8) |  |  | 0.2 |  |  | 3.3 |  |  | (1.2) |
Total derivative instrument impact on comprehensive income, net of tax | $ | 5.5 |  |  | $ | 7.0 |  |  |  |  |  |  | $ | 1.7 |  |  | $ | (33.7) |  |  | $ | 7.2 |  |  | $ | (26.7) |

| Contracts |  |
| Foreign Exchange |  |  |  | Interest rate |  | Total
| Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  |  |  |  |  | 2020 |  | 2019 |  | 2020 |  | 2019
Unrealized hedging gains (losses) and other, net of tax | $ | 27.4 |  |  | $ | 4.6 |  |  |  |  |  |  | $ | 1.9 |  |  | $ | (66.6) |  |  | $ | 29.3 |  |  | $ | (62.0) |
Reclassification of deferred hedging (gains) losses, net of tax (1) | (14.1) |  |  | (8.2) |  |  |  |  |  |  | (1.3) |  |  | 0.2 |  |  | (15.4) |  |  | (8.0) |
Total derivative instrument impact on comprehensive income, net of tax | $ | 13.3 |  |  | $ | (3.6) |  |  |  |  |  |  | $ | 0.6 |  |  | $ | (66.4) |  |  | $ | 13.9 |  |  | $ | (70.0) |

___________________
(1)See Note 15 for classification of amounts within the condensed consolidated statements of income (loss).
Derivatives Not Designated as Hedging Instruments

|  |  | Amount of Pre-tax Gain (Loss) Recognized in Income on Derivatives (1)
|  |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | Location of Gain or (Loss) Recognized in Income on Derivatives |  | 2020 |  | 2019 |  | 2020 |  | 2019
Foreign exchange contracts | Cost of sales and services |  | $ | (14.3) |  |  | $ | (0.3) |  |  | $ | (38.4) |  |  | $ | (11.8) |
Total |  |  | $ | (14.3) |  |  | $ | (0.3) |  |  | $ | (38.4) |  |  | $ | (11.8) |

___________________
(1)Amounts represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item.
Fair Value Measurements
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Market participants are defined as buyers or sellers in the principle or most advantageous market for the asset or liability that are independent of the reporting entity, knowledgeable and able and willing to transact for the asset or liability.
32

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Fair Value Hierarchy
We have categorized our assets and liabilities that are recorded at fair value, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets and liabilities fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
Recurring Fair Value Measurements
The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets. During the periods presented there were no transfers between fair value hierarchy levels.

(in Millions) | September 30, 2020 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 19.1 |  |  | $ | — |  |  | $ | 19.1 |  |  | $ | — |
Other (2) | 21.8 |  |  | 21.8 |  |  | — |  |  | — |
Total assets | $ | 40.9 |  |  | $ | 21.8 |  |  | $ | 19.1 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 5.4 |  |  | $ | — |  |  | $ | 5.4 |  |  | $ | — |
Derivatives – Interest rate (1) | 3.4 |  |  | — |  |  | 3.4 |  |  | — |
Other (3) | 33.7 |  |  | 32.1 |  |  | 1.6 |  |  | — |
Total liabilities | $ | 42.5 |  |  | $ | 32.1 |  |  | $ | 10.4 |  |  | $ | — |

(in Millions) | December 31, 2019 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 0.2 |  |  | $ | — |  |  | $ | 0.2 |  |  | $ | — |
Other (2) | 20.2 |  |  | 20.2 |  |  | — |  |  | — |
Total assets | $ | 20.4 |  |  | $ | 20.2 |  |  | $ | 0.2 |  |  | $ | — |
Liabilities |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 8.2 |  |  | $ | — |  |  | $ | 8.2 |  |  | $ | — |
Derivatives – Interest rate (1) | 0.9 |  |  | — |  |  | 0.9 |  |  | — |
Other (3) | 32.8 |  |  | 29.7 |  |  | 3.1 |  |  | — |
Total liabilities | $ | 41.9 |  |  | $ | 29.7 |  |  | $ | 12.2 |  |  | $ | — |

____________________
(1)See the Fair Value of Derivative Instruments table within this Note for classification on the condensed consolidated balance sheets.
(2)Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheets. Both the asset and liability are recorded at fair value. Asset amounts are included in "Other assets including long-term receivables, net" in the condensed consolidated balance sheets.
(3)Primarily consists of a deferred compensation arrangement recognized on our balance sheets. Both the asset and liability are recorded at fair value. Liability amounts are included in "Other long-term liabilities" in the condensed consolidated balance sheets.
Nonrecurring Fair Value Measurements
There were no non-recurring fair value measurements in the condensed consolidated balance sheets during the periods presented.
33

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 19: Guarantees, Commitments, and Contingencies
We continue to monitor the conditions that are subject to guarantees and indemnifications to identify whether a liability must be recognized in our financial statements.
Guarantees and Other Commitments
The following table provides the estimated undiscounted amount of potential future payments for each major group of guarantees at September 30, 2020. These guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates. Non-performance by the guaranteed party triggers the obligation requiring us to make payments to the beneficiary of the guarantee. Based on our experience these types of guarantees have not had a material effect on our consolidated financial position or on our liquidity. Our expectation is that future payment or performance related to the non-performance of others is considered unlikely.

(in Millions) |
Guarantees: |
Guarantees of vendor financing - short-term (1) | $ | 97.0 |
Other debt guarantees (2) | — |
Total | $ | 97.0 |

____________________
(1)Represents guarantees to financial institutions on behalf of certain customers for their seasonal borrowing. This short-term amount is recorded within "Guarantees of vendor financing" on the condensed consolidated balance sheets.
(2)These guarantees represent support provided to third-party banks for credit extended to various customers and nonconsolidated affiliates. The liability for the guarantees is recorded at an amount that approximates fair value (i.e. representing the stand-ready obligation) based on our historical collection experience and a current assessment of credit exposure. We believe the fair value of these guarantees is immaterial. The majority of these guarantees have an expiration date of less than one year.
Excluded from the chart above are parent-company guarantees we provide to lending institutions that extend credit to our foreign subsidiaries. Since these guarantees are provided for consolidated subsidiaries, the consolidated financial position is not affected by the issuance of these guarantees. Also excluded from the chart, in connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale or provided guarantees to third parties relating to certain contracts assumed by the buyer. Our indemnification or guarantee obligations with respect to certain liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover some of the indemnity payments from third parties. Therefore, we have not recorded any specific liabilities for these guarantees. For certain obligations related to our divestitures for which we can make a reasonable estimate of the maximum potential loss or range of loss and is probable, a liability in those instances has been recorded.
Contingencies
A detailed discussion related to our outstanding contingencies can be found in Note 20 to our consolidated financial statements included within our 2019 Form 10-K. There have been no significant updates since the information included in our 2019 Form 10-K other than the update provided below.
34

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Livent IPO
Livent Corporation class action. On May 13, 2019, purported stockholders of our former subsidiary Livent Corporation (“Livent”) filed a putative class action complaint in the Pennsylvania Court of Common Pleas, Philadelphia County, in connection with Livent’s October 2018 initial public offering (the “Livent IPO”). The complaint in this case, Plymouth County Retirement Association v. Livent Corp., et al., named as defendants Livent, certain of its current and former executives and directors, FMC Corporation, and underwriters involved in the Livent IPO (“Defendants”). The complaint alleges generally that the offering documents for the Livent IPO failed to adequately disclose certain information related to Livent’s business and prospects. The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and seeks unspecified damages and other relief on behalf of all persons and entities who purchased or otherwise acquired Livent common stock pursuant and/or traceable to the Livent IPO offering documents. On July 2, 2019, Defendants moved to stay the Plymouth County action, in favor of two similar putative class actions relating to the Livent IPO, in which FMC had not been named as a Defendant, which are pending in the United States District Court of the Eastern District of Pennsylvania. On July 18, 2019, a separate state action was filed against the same Defendants in the Pennsylvania Court of Common Pleas, Philadelphia County, Bizzaria v. Livent Corp., et al. On July 26, 2019, Plymouth County filed an amended complaint in its state court case. On September 23, 2019, the actions were consolidated under the caption In re Livent Corporation Securities Litigation, No. 190501229. On October 11, 2019, Defendants filed preliminary objections seeking to dismiss the case in its entirety. On October 22, 2019, the Court denied Defendants’ motion to stay the case, but granted a separate motion of the Defendants to stay all discovery. On June 29, 2020, the court overruled the preliminary objections filed by the Defendants and on July 29, 2020, Defendants filed a motion seeking permission to appeal the state court's order.
Separately, on October 18, 2019, purported stockholders of Livent amended a putative class action complaint filed in the U.S. District Court for the Eastern District of Pennsylvania, to add FMC Corporation as a defendant. The operative complaint in that case, Bisser Nikolov v. Livent Corp., et al. makes similar substantive allegations as the state court case, including alleged violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 and seeks unspecified damages and other relief on behalf of all persons and entities who purchased or otherwise acquired Livent common stock pursuant and/or traceable to the Livent IPO offering documents. Pursuant to a stipulated scheduling order, Defendants filed a motion to dismiss the Nikolov case on November 18, 2019. Plaintiffs filed their opposition to the motion to dismiss on December 30, 2019. On July 2, 2020, the federal court granted the Defendants' motion to dismiss and dismissed the federal complaint in its entirety and on July 31, 2020, Plantiffs filed a notice of appeal.
On October 28, 2020, Defendants entered into a stipulation of settlement with the state court plaintiffs in which Livent, on behalf of the Defendants, will pay $7.4 million to resolve all claims related to the IPO. On October 29, 2020, the state court plaintiffs filed a motion seeking preliminary approval of the settlement. If approved, the settlement would resolve all pending litigation relating to the IPO, including the claims in both the state and federal actions. All deadlines in the state and federal actions are currently stayed in light of the settlement. There is no financial impact to FMC as a result of the settlement. Livent has agreed to defend and indemnify FMC with regard to these cases. FMC is cooperating with Livent and other Defendants to defend the litigation.
35

Table of Content s
FMC CORPORATION
Notes to Condensed Consolidated Financial Statements (unaudited) — (Continued)
Note 20: Subsequent Events
In May 2020, FMC entered into a binding offer with Isagro S.p.A ("Isagro") to acquire the remaining rights for Fluindapyr active ingredient assets from Isagro. In July 2020, we entered into an asset sale and purchase agreement with Isagro. On October 2, 2020, we closed on the transaction with a purchase price of approximately $65 million. Fluindapyr has been jointly developed by FMC and Isagro under a 2012 research and development collaboration agreement. The transaction provides FMC with full global rights to the Fluindapyr active ingredient, including key U.S., European, Asian, and Latin American fungicide markets. The transaction transfers to FMC all intellectual property, know-how, registrations, product formulations and other global assets of the proprietary broad-spectrum fungicide molecule.
The Fluindapyr acquisition does not meet the criteria within ASC 805 to qualify as a business and as a result it will be treated as an asset acquisition. Based on the current development stage of the technology, the acquired assets have been classified as in-process research and development. As part of our evaluation, we consider the current development phase of the molecule being acquired. Molecules that have not received formal regulatory approval are still considered in process due to the inherent uncertainty with the approval process. As a result, these assets will be immediately expensed resulting in a charge of approximately $65 million in the fourth quarter of 2020. While this transaction will result in an immediate expense of the purchase price under the accounting rules, this acquisition will expand our fungicide portfolio by giving us full global rights to the Fluindapyr active ingredient and is an important strategic addition to our product line.
36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.
Whenever possible, we have identified these forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Currently, one of the most significant factors is the potential adverse effect of the current COVID-19 pandemic on our financial condition, results of operations, cash flows and performance, which is substantially influenced by the potential adverse effect of the pandemic on our customers and suppliers and the global economy and financial markets. The extent to which COVID-19 impacts us will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact, and the direct and indirect economic effects of the pandemic and containment measures, among others. Additional factors include, among other things, the risk factors included in Part II, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019 (the "2019 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2019 Form 10-K, the risk factor in Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). Moreover, investors are cautioned to interpret many of these factors as being heightened as a result of the ongoing and numerous adverse impacts of COVID-19. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.
We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2019 Form 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.
The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the "Critical Accounting Policies" section in our 2019 Form 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.
•Revenue recognition and trade receivables
•Environmental obligations and related recoveries
•Impairment and valuation of long-lived assets and indefinite-lived assets
•Pensions and other postretirement benefits
•Income taxes
On January 1, 2020, ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, became effective. See Note 2 for more information. Our revenue recognition and trade receivables critical accounting policy has been updated in order to comply with the accounting standard update. The updated policy refines the process of estimating the allowance for doubtful accounts receivables by incorporating past events, current business conditions, and reasonable and supportable forecasts of future economic conditions that affect the collectability of the reported amounts.
37

RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS
See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.
OVERVIEW
We are an agricultural sciences company, providing innovative solutions to growers around the world with a robust product portfolio fueled by a market-driven discovery and development pipeline in crop protection, plant health, and professional pest and turf management. We operate in a single distinct business segment and develop, market and sell all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. This powerful combination of advanced technologies includes leading insect control products based on Rynaxypyr® and Cyazypyr® active ingredients; Authority®, Boral®, Centium®, Command® and Gamit® branded herbicides; Talstar® and Hero® branded insecticides; and flutriafol-based fungicides. The FMC portfolio also includes biologicals such as Quartzo® and Presence® bionematicides.
COVID-19 Pandemic
In March 2020, the World Health Organization characterized COVID-19 as a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The rapid spread of the outbreak has caused significant disruptions in the U.S. and global economies, and economists expect the impact will continue to be significant during the remainder of 2020 and beyond.
As an agricultural sciences company, we are considered an "essential" industry in the countries in which we operate; we have avoided significant plant closures and all our manufacturing facilities and distribution warehouses remain operational and fully staffed. We delivered strong financial performance and navigated the challenges posed by COVID-19 and severe foreign currency headwinds. While we have maintained business continuity and sustained our operations with safety as a priority, we do not yet know the full extent of the disruptions on either our business and operations or the global economy nor the duration of the pandemic and its adverse effects.
We have implemented new procedures to support the health and safety of our employees and we are following all U.S. Centers for Disease Control and Prevention, as well as state and regional health department guidelines. The well-being of our employees is FMC's top priority. Although most FMC office-based employees around the world have been working remotely during this period, we have implemented procedures to safely return to the workplace in regions where the pandemic is controlled and local health officials have deemed this to be safe in compliance with any government regulations. In addition, we have thousands of employees who continue operating our manufacturing sites and distribution warehouses. In all our facilities, we are using a variety of best practices to address COVID-19 risks, following the protocols and procedures recommended by leading health authorities. We are monitoring the situation in regions where the pandemic continues to escalate and in such regions will remain in a remote working environment until it is safe to return to the workplace. In the first three quarters of 2020, we have made significant investments in our employees as a result of the COVID-19 pandemic, including through enhanced dependent care pay policies, recognition bonuses, increased flexibility of work schedules and hours of work to accommodate remote working arrangements, and investment in IT infrastructure to promote remote work. Through these efforts we have successfully avoided any COVID-19 related furloughs or workforce reductions to date.
In addition to addressing the needs of the Company and our employees, FMC has been a leader in supporting the needs of the communities in which FMC has operations and those generally in need as a result of the pandemic. Since the advent of the pandemic, we have donated in excess of 233,000 personal protective equipment supplies, including N95 masks, surgical masks, protective cover suits, goggles and similar items. We have also donated more than 1,800 containers and canisters used to transport alcohol-based disinfecting solution. Additional efforts include financial contributions to hunger-relief organizations; assisting with disinfecting schools and other public spaces in villages; and supporting various community initiatives.
38

In our supply chain, sourcing of raw materials and intermediates was not a significant issue, although we continued to see some logistics challenges and related higher costs. While we saw very strong demand for our products in all four regions of the world in the third quarter, there were pockets of demand reduction related to the pandemic. This impacted certain cotton and fruit and vegetable markets. Underlying demand for our products remains healthy, supplemented by market access expansion, new registrations, and an increasing impact from our pricing actions as we enter the fourth quarter. We are conscious of the potential downside risks in the remainder of the year and expect to continue to experience disruption caused by COVID-19 in our supply chain, logistics, and pockets of demand, as well as on farm worker labor required for planting, harvesting and packing crops (especially fruits, vegetables and other specialty crops) in the food chain going forward. As discussed in the first two quarters of 2020, we implemented price increases and cost-saving measures across the company to offset impacts of the COVID-19 pandemic and related foreign currency headwinds. We amended our debt covenants with our banks on April 22, 2020 (see Note 11 for more details) to provide significant additional headroom above any of the COVID-19 related scenarios assessed by the company. We will continue to monitor the economic environment related to the pandemic on an ongoing basis and assess the impacts on our business.
Third Quarter 2020 Highlights
The following items are the more significant developments or financial highlights in our business during the three months ended September 30, 2020:
•Revenue of $1,084.6 million for the three months ended September 30, 2020 increased $70.3 million or approximately 7 percent versus the same period last year. A more detailed review of revenue is discussed under the section titled "Results of Operations". On a regional basis, sales in North America increased by approximately 8 percent, sales in Latin America increased approximately 1 percent, sales in Europe, Middle East and Africa increased by approximately 10 percent, and sales in Asia increased approximately 16 percent. The increase was mostly driven by higher volumes and pricing. Excluding foreign currency impacts, revenue increased 15 percent during the quarter and our business saw double digit growth in India, Australia, Pakistan, Brazil, Germany, Italy and Canada.
•Our gross margin of $466.4 million increased versus the prior year quarter by $34.0 million driven by volume growth. Gross margin percent of approximately 43 percent remained flat compared to approximately 43 percent in the prior year period.
•We previously implemented temporary cost-saving measures and are continuing to eliminate or delay all non-essential expenditures to offset projected headwinds from the effects of the COVID-19 pandemic. These efforts are primarily focused on selling, general and administrative expenses and research and development expenses. We are not cancelling any research and development projects, but we are phasing some differently to allow for lower costs in the current year without fundamentally impacting long-term timelines.
•Selling, general and administrative expenses decreased from $188.3 million to $187.7 million. Selling, general and administrative expenses, excluding transaction-related charges, of $173.3 million increased approximately 1 percent compared to the prior year.
•Research and development expenses of $71.7 million decreased $5.7 million or approximately 7 percent. As mentioned above, we did not cancel any research and development projects, but we phased some differently to allow lower costs this year in response to the pandemic without fundamentally impacting long-term timelines. We maintain our commitment to invest resources to discover new active ingredients and formulations that support resistance management and sustainable agriculture.
•Net income (loss) attributable to FMC stockholders increased from $90.4 million to $111.4 million which represents an increase of $21 million, or approximately 23 percent. Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $160.1 million increased compared to the prior year amount of $124.2 million. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
Other Highlights
On October 2, 2020, we closed on the previously disclosed transaction with Isagro S.p.A ("Isagro") for a purchase price of approximately $65 million, which will result in a charge in the fourth quarter of 2020. The Fluindapyr acquisition will be treated as an asset acquisition for accounting purposes as it does not meet the definition of a business. Therefore, any acquired in-process research and development will be immediately expensed. See Note 20 in the condensed consolidated financial statements included in this Form 10-Q for further details.
39

2020 Outlook Update
With a few months remaining in 2020, we continue to expect the overall global crop protection market to be flat to down slightly, on a U.S. dollar basis, although our view on the regions has slightly changed. The outlook for Europe continues to worsen, following a hot and dry summer, and now we believe that market will be down low-single digits year over year, versus flat in our prior forecast. Offsetting this, we expect the Asian market to be up low-single digits, versus our prior forecast of it being down slightly. Our forecasts for the Latin American and North American markets are unchanged at down low- to mid-single digits and up low- single digits, respectively.
We expect continued headwinds from foreign currency, and to a lesser extent, from impacts related to the pandemic. At the onset of the pandemic, there were numerous contingencies to consider, but after several months of navigating in this environment, we have better insight. We are raising the midpoints of our adjusted EBITDA and adjusted EPS guidance and tightening those ranges. We now expect 2020 revenue will be in the range of approximately $4.72 billion to $4.78 billion, up approximately 3 percent at the midpoint versus 2019 or approximately 9 percent excluding the impacts of foreign currency. Full year adjusted EBITDA(1) is now expected to be $1.295 billion to $1.315 billion, representing 7 percent growth at the midpoint versus 2019 results and an increase of 1 percent versus prior guidance. 2020 adjusted earnings are expected to be in the range of $6.45 to $6.57 per diluted share(1), representing a year over year increase of 7 percent at the midpoint and 6 cents higher than prior forecast. Full-year earnings growth drivers include significant volume gains in Latin America and Asia, global pricing improvement and continued cost discipline. Planned fourth quarter share repurchases of $50 million are not expected to have any material impact on FMC diluted shares outstanding in the current year. For cash flow outlook, refer to the liquidity and capital resources section below.
(1)Although we provide forecasts for adjusted earnings per share and adjusted EBITDA (Non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with U.S. GAAP. Certain elements of the composition of the U.S. GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no U.S. GAAP outlook is provided.
40

RESULTS OF OPERATIONS
Overview
The following charts provide a reconciliation of Adjusted EBITDA and Adjusted Earnings, both of which are Non-GAAP financial measures, from the most directly comparable GAAP measure. Adjusted EBITDA is provided to assist the readers of our financial statements with useful information regarding our operating results. Our operating results are presented based on how we assess operating performance and internally report financial information. For management purposes, we report operating performance based on earnings before interest, income taxes, depreciation and amortization, discontinued operations, and corporate special charges. Our Adjusted Earnings measure excludes corporate special charges, net of income taxes, discontinued operations attributable to FMC stockholders, net of income taxes, and certain Non-GAAP tax adjustments. These are excluded by us in the measure we use to evaluate business performance and determine certain performance-based compensation. These items are discussed in detail within the "Other Results of Operations" section that follows. In addition to providing useful information about our operating results to investors, we also believe that excluding the effect of corporate special charges, net of income taxes, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying business from period to period. These measures should not be considered as substitutes for net income (loss) or other measures of performance or liquidity reported in accordance with U.S. GAAP.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
(in Millions) | (unaudited) |  | (unaudited)
Revenue | $ | 1,084.6 |  |  | $ | 1,014.3 |  |  | $ | 3,489.9 |  |  | $ | 3,412.5 |
Costs of sales and services | 618.2 |  |  | 581.9 |  |  | 1,939.3 |  |  | 1,884.9 |
Gross margin | $ | 466.4 |  |  | $ | 432.4 |  |  | $ | 1,550.6 |  |  | $ | 1,527.6 |
Selling, general and administrative expenses | 187.7 |  |  | 188.3 |  |  | 548.1 |  |  | 569.1 |
Research and development expenses | 71.7 |  |  | 77.4 |  |  | 203.3 |  |  | 221.7 |
Restructuring and other charges (income) | 11.0 |  |  | 6.8 |  |  | 43.9 |  |  | 27.3 |
Total costs and expenses | $ | 888.6 |  |  | $ | 854.4 |  |  | $ | 2,734.6 |  |  | $ | 2,703.0 |
Income from continuing operations before non-operating pension and postretirement charges (income), interest expense, net and income taxes (1) | $ | 196.0 |  |  | $ | 159.9 |  |  | $ | 755.3 |  |  | $ | 709.5 |
Non-operating pension and postretirement charges (income) | 11.6 |  |  | (1.2) |  |  | 16.0 |  |  | 5.5 |
Interest expense, net | 35.5 |  |  | 41.6 |  |  | 117.0 |  |  | 115.6 |
Income (loss) from continuing operations before income taxes | $ | 148.9 |  |  | $ | 119.5 |  |  | $ | 622.3 |  |  | $ | 588.4 |
Provision (benefit) for income taxes | 18.4 |  |  | 8.7 |  |  | 82.3 |  |  | 75.6 |
Income (loss) from continuing operations | $ | 130.5 |  |  | $ | 110.8 |  |  | $ | 540.0 |  |  | $ | 512.8 |
Discontinued operations, net of income taxes | (18.4) |  |  | (21.3) |  |  | (36.7) |  |  | (29.8) |
Net income (loss) (GAAP) | $ | 112.1 |  |  | $ | 89.5 |  |  | $ | 503.3 |  |  | $ | 483.0 |
Adjustments to arrive at Adjusted EBITDA: |  |  |  |  |  |  |
Corporate special charges (income): |  |  |  |  |  |  |
Restructuring and other charges (income) (3) | $ | 11.0 |  |  | $ | 6.8 |  |  | $ | 43.9 |  |  | $ | 27.3 |
Non-operating pension and postretirement charges (income) (4) | 11.6 |  |  | (1.2) |  |  | 16.0 |  |  | 5.5 |
Total transaction-related charges (5) | 14.4 |  |  | 16.0 |  |  | 40.4 |  |  | 52.6 |
Discontinued operations, net of income taxes | 18.4 |  |  | 21.3 |  |  | 36.7 |  |  | 29.8 |
Interest expense, net | 35.5 |  |  | 41.6 |  |  | 117.0 |  |  | 115.6 |
Depreciation and amortization | 41.5 |  |  | 36.6 |  |  | 120.7 |  |  | 111.1 |
Provision (benefit) for income taxes | 18.4 |  |  | 8.7 |  |  | 82.3 |  |  | 75.6 |
Adjusted EBITDA (Non-GAAP) (2) | $ | 262.9 |  |  | $ | 219.3 |  |  | $ | 960.3 |  |  | $ | 900.5 |

____________________
(1) Referred to as operating profit.
(2) Adjusted EBITDA is defined as operating profit excluding corporate special charges (income) and depreciation and amortization expense.
41

(3) See Note 10 for details of restructuring and other charges (income).
(4) Our non-operating pension and postretirement charges (income) are defined as those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our operating results and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our operating results noted above. These elements reflect the current year operating costs to our business for the employment benefits provided to active employees.
(5) Represents transaction costs, costs for transitional employees, other acquired employees related costs, and transactional-related costs such as legal and professional third-party fees. Except for the completion of certain in-flight initiatives, primarily associated with the finalization of our worldwide ERP system, we completed the integration of the DuPont Crop Protection Business as of June 30, 2020. The TSA is now terminated and the last phase of the ERP system transition went live in November 2020 with a stabilization period that will go into the first quarter of 2021. We anticipate remaining expense of approximately $15 million to $20 million for the completion of these defined in-flight initiatives during the remaining time period.

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
DuPont Crop Protection Business Acquisition |  |  |  |  |  |  |
Legal and professional fees (1) | $ | 14.4 |  |  | $ | 16.0 |  |  | $ | 40.4 |  |  | $ | 52.6 |
Total Transaction-related charges | $ | 14.4 |  |  | $ | 16.0 |  |  | $ | 40.4 |  |  | $ | 52.6 |

____________________
(1) These charges are recorded as a component of "Selling, general and administrative expense" on the condensed consolidated statements of income (loss).

ADJUSTED EARNINGS RECONCILIATION
| Three Months Ended September 30, |  | Nine Months Ended September 30,
2020 |  | 2019 |  | 2020 |  | 2019
(in Millions) | (unaudited) |  | (unaudited)
Net income (loss) attributable to FMC stockholders (GAAP) | $ | 111.4 |  |  | $ | 90.4 |  |  | $ | 502.0 |  |  | $ | 480.6 |
Corporate special charges (income), pre-tax (1) | 37.0 |  |  | 21.6 |  |  | 100.3 |  |  | 85.4 |
Income tax (expense) benefit on Corporate special charges (income) (2) | (6.1) |  |  | 0.8 |  |  | (16.9) |  |  | (12.0) |
Corporate special charges (income), net of income taxes | $ | 30.9 |  |  | $ | 22.4 |  |  | $ | 83.4 |  |  | $ | 73.4 |
Discontinued operations attributable to FMC Stockholders, net of income taxes | 18.4 |  |  | 21.3 |  |  | 36.7 |  |  | 29.8 |
Non-GAAP tax adjustments (3) | (0.6) |  |  | (9.9) |  |  | 1.6 |  |  | (10.1) |
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP) | $ | 160.1 |  |  | $ | 124.2 |  |  | $ | 623.7 |  |  | $ | 573.7 |

____________________
(1) Represents restructuring and other charges (income), non-operating pension and postretirement charges (income), and transaction-related charges.
(2) The income tax expense (benefit) on corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the corporate special charge (income) occurred and includes both current and deferred income tax expense (benefit) based on the nature of the Non-GAAP performance measure.
(3) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to current year ongoing business operations; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; and certain changes in the realizability of deferred tax assets. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.
42

Results of Operations
In the discussion below, all comparisons are between the periods unless otherwise noted.
Revenue
Three Months Ended September 30, 2020 vs. 2019
Revenue of $1,084.6 million increased $70.3 million, or approximately 7 percent, versus the prior year period. The increase was driven by higher volumes, which accounted for an approximate 12 percent increase, as well as favorable pricing which accounted for an approximate 3 percent increase. Foreign currency headwinds had an unfavorable impact of approximately 8 percent on revenue. Excluding foreign currency impacts, revenue increased approximately 15 percent during the quarter.
Nine Months Ended September 30, 2020 vs. 2019
Revenue of $3,489.9 million increased $77.4 million, or approximately 2 percent, versus the prior year period. The increase was driven by higher volumes, which accounted for an approximate 7 percent increase, as well as favorable pricing which accounted for an approximate 2 percent increase. Foreign currency fluctuations had an unfavorable impact of approximately 7 percent on revenue. See below for a discussion of revenue by region.

Total Revenue by Region
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
North America | $ | 212.3 |  |  | $ | 196.3 |  |  | $ | 851.8 |  |  | $ | 848.1 |
Latin America | 464.9 |  |  | 460.2 |  |  | 985.3 |  |  | 923.4 |
Europe, Middle East & Africa (EMEA) | 152.8 |  |  | 138.4 |  |  | 833.5 |  |  | 854.7 |
Asia | 254.6 |  |  | 219.4 |  |  | 819.3 |  |  | 786.3 |
Total Revenue | $ | 1,084.6 |  |  | $ | 1,014.3 |  |  | $ | 3,489.9 |  |  | $ | 3,412.5 |

Three Months Ended September 30, 2020 vs. 2019
North America: Revenue increased approximately 8 percent versus the prior year period driven by increased planted acres in soybean, corn and rice, as well as continued market expansions of our fungicides Lucento® and Rhyme®. Sales in Canada were robust, driven by cereal herbicide blends from our patented PrecisionPac® technology and insecticides.
Latin America: Revenue increased approximately 1 percent versus the prior year period, or approximately 18 percent excluding foreign currency headwinds. The beginning of the season was slow due to hot and dry weather in Brazil, Argentina and Paraguay. Pricing actions across the region offset some of the currency headwind. In Brazil, sales grew double digits organically, led by our growth in the soybean market. Mexico sales grew organically but were still impacted somewhat by COVID-19 related pressures on the growers that export fruits and vegetables. Sales in the Andean zone grew significantly as conditions in that sub-market improved.
EMEA: Revenue increased approximately 10 percent versus the prior year period, with no foreign currency impact. We saw strong demand for Rynaxypyr® insect control applications for specialty crops as well as Battle® Delta herbicides for cereals, particularly in France and Germany.
Asia: Revenue increased approximately 16 percent versus the prior year period, or approximately 19 percent excluding foreign currency headwinds, partially due to favorable weather in both India and Australia. Sales in India grew over 20 percent organically, as the favorable monsoon drove demand from growers of rice, soybeans, pulses, sugarcane and fruit and vegetables in the south and central markets. Herbicide sales in Australia were up over 50 percent, led by cereals and canola. Pakistan also grew in double-digits, driven primarily by insecticides in rice and cotton.
Nine Months Ended September 30, 2020 vs. 2019
North America: Revenue increased slightly versus the prior year period due to strong demand for our new pre-emergent herbicide Authority® Edge and fungicides. Double digit growth in Canada was driven by cereal herbicide blends from our PrecisionPac® technology and insecticides and continued adoption of our Authority® herbicides due to resistance concerns. This was partially offset by continued focus on drawing down inventories of our pre-emergent herbicides at our distributors.
Latin America: Revenue increased approximately 7 percent versus the prior year period, or approximately 24 percent excluding foreign currency headwinds, driven by strong growth in Argentina and double-digit growth in Brazil. Insecticide growth in Brazil was driven by sugarcane and soybeans, and herbicide growth was driven by sugarcane replanting. In Argentina, insecticide and herbicide demand drove sales for soybeans and wheat.
43

EMEA: Revenue decreased approximately 2 percent versus the prior year period, or remained flat excluding foreign currency headwinds, primarily due to hot, dry conditions across Northern and Eastern Europe and Ukraine, as well as expected registration cancellations and product rationalizations. This was partially offset by strong demand for Rynaxypyr® insect control applications for specialty crops as well as Battle® Delta herbicides for cereals.
Asia: Revenue increased approximately 4 percent versus the prior year period, or approximately 9 percent excluding foreign currency headwinds, primarily driven by volume growth in India, Australia and Pakistan, as well as modest pricing increases across the region. Herbicide sales, including for the newly launched Authority® NXT, were robust for soybeans in India.
For 2020, full-year revenue is expected to be in the range of approximately $4.72 billion to $4.78 billion, which represents approximately 3 percent growth at the midpoint versus 2019 or approximately 9 percent excluding the impacts of foreign currency.
Gross margin
Three Months Ended September 30, 2020 vs. 2019
Gross margin of $466.4 million increased $34.0 million, or approximately 8 percent versus the prior year period. The increase was primarily due to higher revenues which were driven by volume growth.
Gross margin percent of approximately 43 percent remained flat compared to approximately 43 percent in the prior year period.
Nine Months Ended September 30, 2020 vs. 2019
Gross margin of $1,550.6 million increased $23 million, or approximately 2 percent versus the prior year period.
Gross margin percent of approximately 44 percent decreased slightly from approximately 45 percent in the prior year period.
Selling, general and administrative expenses
Three Months Ended September 30, 2020 vs. 2019
Selling, general and administrative expenses of $187.7 million decreased $0.6 million, or remained relatively flat, versus the prior year period. Selling, general and administrative expenses, excluding transaction-related charges, increased $1.0 million, or approximately 1 percent, versus the prior year period.
Nine Months Ended September 30, 2020 vs. 2019
Selling, general and administrative expenses of $548.1 million decreased $21.0 million, or approximately 4 percent versus the prior year period. Selling, general and administrative expenses, excluding transaction-related charges, decreased $8.8 million, or approximately 2 percent, versus the prior year period due to cost-saving measures implemented in response to the pandemic.
Research and development expenses
Three Months Ended September 30, 2020 vs. 2019
Research and development expenses of $71.7 million decreased $5.7 million, or approximately 7 percent versus the prior year period. As noted above, we eliminated or delayed certain non-essential expenditures to offset effects of the COVID-19 pandemic, but we did not cancel any research and development projects. We phased some projects differently to allow lower costs this year in response to the pandemic without fundamentally impacting long-term timelines.
Nine Months Ended September 30, 2020 vs. 2019
Research and development expenses of $203.3 million decreased $18.4 million, or approximately 8 percent versus the prior year period. As noted above, the decrease in research and development expenditures is related to cost-saving measures taken in response to the COVID-19 pandemic.
44

Adjusted EBITDA (Non-GAAP)
Three Months Ended September 30, 2020 vs. 2019
Adjusted EBITDA of $262.9 million increased $43.6 million, or approximately 20 percent versus the prior year period. The increase was mainly driven by volume increases, primarily in Latin America and Asia, which accounted for an approximate 32 percent increase. Cost control actions and price increases accounted for approximately 15 percent and 12 percent increases, respectively. These more than offset foreign currency fluctuations which had an unfavorable impact of approximately 39 percent on Adjusted EBITDA.
Nine Months Ended September 30, 2020 vs. 2019
Adjusted EBITDA of $960.3 million increased $59.8 million, or approximately 7 percent versus the prior year period. The increase was due to higher pricing and higher volumes which accounted for approximately 7 percent and 13 percent increases, respectively. Cost control actions accounted for an approximate 8 percent increases. These factors more than offset the foreign currency fluctuations which had an unfavorable impact of approximately 21 percent on Adjusted EBITDA.
For 2020, full-year Adjusted EBITDA is expected to be in the range of $1.295 billion to $1.315 billion, which represents approximately 7 percent growth at the midpoint versus 2019. We expect strong pricing and higher volumes to cover the full impact of the negative foreign currency impacts. Although we provide a forecast for Adjusted EBITDA, a Non-GAAP financial measure, we are not able to forecast the most directly comparable measure calculated and presented in accordance with U.S. GAAP. See Note 1 to our 2020 Outlook Update within this section of the Form 10-Q.
Other Results of Operations
Depreciation and amortization
Three Months Ended September 30, 2020 vs. 2019
Depreciation and amortization of $41.5 million increased $4.9 million, or approximately 13 percent, as compared to the prior year period of $36.6 million. The increase was mostly driven by the impacts of the amortization effects of the completion of various phases of our ERP implementation.
Nine Months Ended September 30, 2020 vs. 2019
Depreciation and amortization of $120.7 million increased $9.6 million, or approximately 9 percent, as compared to the prior year period of $111.1 million. The increase was mostly driven by the impacts of the amortization effects of the completion of various phases of our ERP implementation.
Interest expense, net
Three Months Ended September 30, 2020 vs. 2019
Interest expense, net of $35.5 million decreased compared to the prior year period of $41.6 million. The decrease was driven by lower term loan and foreign debt balances, lower LIBOR rates and partially offset by the impacts of our third quarter 2019 debt offering which was settled at the end of third quarter 2019.
Nine Months Ended September 30, 2020 vs. 2019
Interest expense, net of $117.0 million increased compared to the prior year period of $115.6 million. The increase was driven by impacts of our third quarter 2019 debt offering partially offset by lower term loan, commercial paper and foreign debt balances and lower LIBOR rates.
Corporate special charges (income)
Restructuring and other charges (income)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Restructuring charges | $ | 6.9 |  |  | $ | 2.6 |  |  | $ | 29.7 |  |  | $ | 14.9 |
Other charges (income), net | 4.1 |  |  | 4.2 |  |  | 14.2 |  |  | 12.4 |
Total restructuring and other charges (income) | $ | 11.0 |  |  | $ | 6.8 |  |  | $ | 43.9 |  |  | $ | 27.3 |

Three Months Ended September 30, 2020 vs. 2019
45

Restructuring charges in 2020 of $6.9 million primarily represent charges associated with the integration of the DuPont Crop Protection Business which was completed during the second quarter of 2020 except for certain in-flight initiatives. These charges include severance, accelerated depreciation on certain fixed assets, and other costs (benefits).
Restructuring charges in 2019 of $2.6 million comprised of charges associated with the integration of the DuPont Crop Protection Business. These charges include severance, accelerated depreciation on certain fixed assets, and other costs (benefits).
Other charges, net in 2020 of $4.1 million consists of charges related to environmental sites.
Other charges, net in 2019 of $4.2 million consists of charges related to environmental sites
Nine Months Ended September 30, 2020 vs. 2019
Restructuring charges in 2020 of $29.7 million primarily comprised of charges associated with the integration of the DuPont Crop Protection Business which was completed during the second quarter of 2020 except for certain in-flight initiatives. These charges include severance, accelerated depreciation on certain fixed assets, and other costs (benefits).
Restructuring charges in 2019 of $14.9 million primarily comprised of charges associated with the integration of the DuPont Crop Protection Business. These charges include severance, accelerated depreciation on certain fixed assets, and other costs (benefits) of $13.2 million. There were other miscellaneous restructuring charges of $1.7 million.
Other charges, net in 2020 of $14.2 million primarily consists of charges related to environmental sites of $13.7 million.
Other charges, net in 2019 of $12.4 million primarily consists of charges related to environmental sites.
Non-operating pension and postretirement charges (income)
Charges for the three months ended September 30, 2020 were $11.6 million compared to income of $1.2 million for the three months ended September 30, 2019. The increase in non-operating pension and post retirement charges (income) is attributable to the continued approach of using the smoothed market related value of assets (MRVA) as opposed to the actual fair value of plan assets in the determination of 2020 expense. This continued approach will create some volatility in our non-operating periodic pension cost since our qualified pension plan is 100 percent fixed income securities.
Charges for the nine months ended September 30, 2020 were $16.0 million compared to $5.5 million for the nine months ended September 30, 2019. As mentioned above, the increase in non-operating pension and post retirement charges (income) is attributable to the continued approach of using the MRVA as opposed to the actual fair value of plan assets in determining the 2020 expense.
Transaction-related charges
A detailed description of the transaction-related charges is included in Note 5 to the condensed consolidated financial statements included within this Form 10-Q.
Provision for income taxes
Given the geographic footprint of our operations globally, a significant amount of our earnings are generated by foreign subsidiaries and taxed at lower statutory rates than the United States federal statutory rate (e.g., Singapore, Hong Kong, and Switzerland). Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax rates or laws; and the potential decision to repatriate certain future foreign earnings on which United States or foreign withholding taxes have not been previously accrued.
Three Months Ended September 30, 2020 vs. 2019
Provision for income taxes for the three months ended September 30, 2020 was $18.4 million resulting in an effective tax rate of 12.4 percent. Provision for income taxes for the three months ended September 30, 2019 was $8.7 million resulting in an effective tax rate of 7.3 percent.
46

| Three Months Ended September 30,
| 2020 |  | 2019
(in Millions) | Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |  | Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate
GAAP - Continuing operations | $ | 148.9 |  | $ | 18.4 |  | 12.4 | % |  | $ | 119.5 |  | $ | 8.7 |  | 7.3 | %
Corporate special charges (income) | 37.0 |  | 6.1 |  |  |  | 21.6 |  | (0.8) |  |
Tax adjustments (1) |  | 0.6 |  |  |  |  | 9.9 |  |
Non-GAAP - Continuing operations | $ | 185.9 |  | $ | 25.1 |  | 13.5 | % |  | $ | 141.1 |  | $ | 17.8 |  | 12.6 | %

_______________
(1) Refer to Note 3 of the Adjusted Earnings Reconciliation table within this section of this Form 10-Q for an explanation of tax adjustments.
The primary drivers for the increase in the effective tax rate for the three months ended September 30, 2020 compared to three months ended September 30, 2019 are shown in the table above. The remaining changes were primarily due to the impact of geographic mix of earnings among our global subsidiaries.
Nine Months Ended September 30, 2020 vs. 2019
Provision for income taxes for the nine months ended September 30, 2020 was $82.3 million resulting in an effective tax rate of 13.2 percent. Provision for income taxes for the nine months ended September 30, 2019 was $75.6 million resulting in an effective tax rate of 12.8 percent.

| Nine Months Ended September 30,
| 2020 |  | 2019
(in Millions) | Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |  | Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate
GAAP - Continuing operations | $ | 622.3 |  | $ | 82.3 |  | 13.2 | % |  | $ | 588.4 |  | $ | 75.6 |  | 12.8 | %
Corporate special charges (income) | 100.3 |  | 16.9 |  |  |  | 85.4 |  | 12.0 |  |
Tax adjustments (1) |  | (1.6) |  |  |  |  | 10.1 |  |
Non-GAAP - Continuing operations | $ | 722.6 |  | $ | 97.6 |  | 13.5 | % |  | $ | 673.8 |  | $ | 97.7 |  | 14.5 | %

_______________
(1) Refer to Note 3 of the Adjusted Earnings Reconciliation table within this section of this Form 10-Q for an explanation of tax adjustments.
The primary drivers for the decrease in the year-to-date effective tax rate for 2020 compared to 2019 are shown in the table above. The remaining changes were primarily due to the impact of geographic mix of earnings among our global subsidiaries.
Discontinued operations, net of income taxes
Our discontinued operations include results of our discontinued FMC Lithium segment, in periods up to its separation on March 1, 2019, as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other post-retirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Three Months Ended September 30, 2020 vs. 2019
Discontinued operations, net of income taxes represented a loss of $18.4 million for the three months ended September 30, 2020 compared to a loss of $21.3 million for the three months ended September 30, 2019. The loss during both the third quarter of 2020 and 2019 was primarily related to adjustments related to the retained liabilities from our previously discontinued operations.
Nine Months Ended September 30, 2020 vs. 2019
Discontinued operations, net of income taxes represented a loss of $36.7 million for the nine months ended September 30, 2020 compared to loss of $29.8 million for the nine months ended September 30, 2019. The loss during both the nine months ended September 30, 2020 and September 30, 2019 was primarily due to adjustments related to the retained liabilities from our previously discontinued operations. Additionally, during the nine months ended September 30, 2019, we finalized the sale of the first of two parcels of land of our discontinued site in Newark, California and recorded a gain of approximately $21 million, net of tax. The gain on sale was fully offset by results of our discontinued FMC Lithium segment, which was a net loss due to separation-related costs, as well as charges from other previously discontinued operations. These events did not
47

recur in the current period. Refer to Note 12 to the condensed consolidated financial statements included within this Form 10-Q for further information.
Net income (loss)
Three Months Ended September 30, 2020 vs. 2019
Net income (loss) increased to $112.1 million from income of $89.5 million in the prior year period. The higher results were driven by higher revenues and cost-saving measures in selling, general, and administrative and research and development expenses due to the pandemic. This was partially offset by higher non-operating pension charges as discussed above.
Nine Months Ended September 30, 2020 vs. 2019
Net income (loss) increased to $503.3 million from income of $483.0 million in the prior year period. The higher results were driven by higher revenues and reduced selling, general, and administrative and research and development expenses due to the pandemic. This was partially offset by higher non-operating pension charges as discussed above.
48

LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents at September 30, 2020 and December 31, 2019, were $297.1 million and $339.1 million, respectively. Of the cash and cash equivalents balance at September 30, 2020, $257.0 million were held by our foreign subsidiaries. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries’ operating activities and future foreign investments. We have not provided income taxes for other additional outside basis differences inherent in our investments in subsidiaries because the investments are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal or remittance. Determining the amount of unrecognized deferred tax liability related to permanent undistributed foreign earnings is not practicable due to the complexity of the hypothetical calculation.
At September 30, 2020, we had total debt of $3,222.4 million as compared to $3,258.8 million at December 31, 2019. Total debt included $3,028.3 million and $3,031.1 million of long-term debt (excluding current portions of $77.9 million and $82.8 million) at September 30, 2020 and December 31, 2019, respectively. Early in the second quarter of 2020 we amended the Revolving Credit Facility and 2017 Term Loan Agreements to increase the maximum leverage ratio, in order to address potential liquidity constraints that might arise due to the COVID-19 pandemic. Although we had not then, and have not since, experienced any liquidity issues as a result of the economic impacts of the pandemic, we determined that it would be prudent to take this step, as the higher leverage ratio provides significant headroom above any of the COVID-19 related scenarios assessed by the company. Additionally, during the second quarter we fully repaid the $500 million revolver draw made late in the first quarter at the height of the pandemic’s impact on short-term financing markets. At September 30, 2020, our remaining borrowing capacity under our credit facility was $1,284.8 million.
As of September 30, 2020, we were in compliance with all of our debt covenants. See Note 11 in the condensed consolidated financial statements included in this Form 10-Q for further details. We remain committed to solid investment grade credit metrics, and expect full-year average leverage to be in line with this commitment in 2020.
Short-term debt, which consists of short-term foreign borrowings and commercial paper borrowings, decreased from $227.7 million at December 31, 2019 to $194.1 million at September 30, 2020. We provide parent-company guarantees to lending institutions providing credit to our foreign subsidiaries.
Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. At September 30, 2020, we had no borrowings under the commercial paper program.
Revolving Credit Facility and 2017 Term Loan Agreement Amendments
On April 22, 2020, we amended both our Revolving Credit Agreement and 2017 Term Loan Agreement which, among other things, increased the maximum leverage ratio financial covenant and added a negative covenant restricting purchases of the Company’s stock if at any time the maximum leverage ratio exceeds 3.5 through the period ending June 30, 2021. See Note 11 for further details.
49

Statement of Cash Flows
Cash provided (required) by operating activities of continuing operations was $313.5 million and $65.8 million for the nine months ended September 30, 2020 and 2019, respectively.
The table below presents the components of net cash provided (required) by operating activities of continuing operations. For comparability, the prior period amounts for "Change in all other operating assets and liabilities" have been recast to reflect the current period presentation.

(in Millions) | Nine Months Ended September 30,
2020 |  | 2019
Income from continuing operations before non-operating pension and postretirement charges (income), interest expense, net and income taxes | $ | 755.3 |  |  | $ | 709.5 |
Restructuring and other charges (income), total transaction-related charges and depreciation and amortization | 205.0 |  |  | 191.0 |
Operating income before depreciation and amortization (Non-GAAP) | $ | 960.3 |  |  | $ | 900.5 |
Change in trade receivables, net (1) | 77.9 |  |  | 118.7 |
Change in guarantees of vendor financing | 21.3 |  |  | 5.9 |
Change in advance payments from customers (2) | (487.4) |  |  | (439.1) |
Change in accrued customer rebates (3) | 247.1 |  |  | 186.2 |
Change in inventories (4) | (141.7) |  |  | (151.8) |
Change in accounts payable (5) | (142.8) |  |  | (119.4) |
Change in all other operating assets and liabilities (6) | 7.9 |  |  | (115.9) |
Operating cash flows (Non-GAAP) | $ | 542.6 |  |  | $ | 385.1 |
Restructuring and other spending (7) | $ | (11.6) |  |  | $ | (15.3) |
Environmental spending, continuing, net of recoveries (8) | 6.9 |  |  | (8.7) |
Pension and other postretirement benefit contributions (9) | (3.6) |  |  | (9.8) |
Net interest payments (10) | (104.2) |  |  | (114.4) |
Tax payments, net of refunds (10) | (63.3) |  |  | (109.6) |
Transaction and integration costs (11) | (53.3) |  |  | (61.5) |
Cash provided (required) by operating activities of continuing operations | $ | 313.5 |  |  | $ | 65.8 |

____________________
(1) Both periods include the impacts of seasonality and the receivable build intrinsic in our business. The change in cash flows related to trade receivables in 2020 was driven by timing of collections as well as higher sales. Collection timing is more pronounced in certain countries such as Brazil where there may be terms significantly longer than the rest of our business. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks. During the nine months ended September 30, 2020, we collected approximately $672 million of receivables in Brazil.
(2) Advance payments are primarily associated within North America and these payments are received in the fourth quarter of each year and recorded as deferred revenue on the balance sheet at December 31. Revenue associated with advance payments is recognized, generally in the first half of each year, as shipments are made and control to the customer takes place.
(3) These rebates are primarily associated within North America, and to a lesser extent Brazil, and in North America generally settle in the fourth quarter of each year given the end of the respective crop cycle. The changes year over year are associated with the mix in sales eligible for rebates and incentives in 2020 compared to 2019 and timing of certain rebate payments.
(4) Changes in inventory are a result of inventory levels being adjusted to take into consideration the change in market conditions.
(5) The change in cash flows related to accounts payable is primarily due to the timing of payments made to suppliers and vendors.
(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities. Additionally, both periods include the effects of the unfavorable contracts amortization of approximately $95 million and $93 million, respectively.
(7) See Note 10 in our condensed consolidated financial statements included in this Form 10-Q for further details.
(8) The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries. During the first quarter of 2020, we entered into a confidential insurance settlement pertaining to coverage at a legacy environmental site, which settlement resulted in a cash payment to FMC in the amount of $20.0 million. Refer to Note 13 for more details.
50

(9) There were no voluntary contributions to our U.S. qualified defined benefit plan for the nine months ended September 30, 2020. There were $7.0 million in voluntary contributions to our U.S. qualified defined benefit plan for the nine months ended September 30, 2019.
(10) Amounts shown in the chart represent net payments of our continuing operations. The decrease in net tax payments as of September 30, 2020 as compared to the comparable period in the prior year is primarily attributable to the deferral of income tax payments in various jurisdictions as a result of the COVID-19 pandemic.
(11) Represents payments for legal and professional fees associated with the DuPont Crop Protection Business Acquisition in addition to costs related to integrating the DuPont Crop Protection Business. See Note 5 to the condensed consolidated financial statements included in this Form 10-Q for more information.
Cash provided (required) by operating activities of discontinued operations was $(66.3) million and $(36.2) million for the nine months ended September 30, 2020 and 2019, respectively.
Cash provided (required) by operating activities of discontinued operations is directly related to environmental, other postretirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. The 2020 period includes approximately $16 million in additional environmental spending compared to the prior period due in part to the timing of certain payments associated with the settlement reached at our Middleport site. The 2019 period includes the operating activities related to our discontinued FMC Lithium segment for the period up to its separation on March 1, 2019 which accounts for the difference period over period.
Cash provided (required) by investing activities of continuing operations was $(100.5) million and $(119.5) million for the nine months ended September 30, 2020 and 2019, respectively.
The change in cash from investing activities of continuing operations during the nine months ended September 30, 2020, as compared to the same period in 2019, was primarily due to lower capital expenditure spending.
Cash provided (required) by investing activities of discontinued operations was $1.1 million and $9.2 million for the nine months ended September 30, 2020 and 2019, respectively.
Cash provided by investing activities of discontinued operations for the nine months ended September 30, 2020 represents the final proceeds, due to a hold back provision, from the sale of the first of two parcels of land of our discontinued site in Newark, California which was sold in the nine months ended September 30, 2019. The original proceeds of approximately $26 million in the nine months ended September 30, 2019 were partially offset by capital expenditures of our discontinued FMC Lithium segment.
Cash provided (required) by financing activities of continuing operations was $(186.4) million and $374.8 million for the nine months ended September 30, 2020 and 2019, respectively.
The change period over period in financing activities of continuing operations is primarily due to proceeds from Senior Notes and repayment of long-term debt in the prior year period offset by the lack of repurchases of common stock under our publicly announced program in 2020 versus $300 million in the prior period. See below discussion for dividend payments which are a component of cash provided (required) by financing activities of continuing operations.
Cash provided (required) by financing activities of discontinued operations was zero and $(37.2) million for the nine months ended September 30, 2020 and 2019, respectively.
Cash required by financing activities of discontinued operations for the nine months ended September 30, 2019 represents debt repayments on FMC Lithium's external debt as well as cash payments associated with the separation of FMC Lithium.
Free Cash Flow
We define free cash flow, a Non-GAAP financial measure, as all cash inflows and outflows excluding those related to financing activities (such as debt repayments, dividends, and share repurchases) and acquisition related investing activities. Free cash flow is calculated as all cash from operating activities reduced by spending for capital additions and other investing activities as well as legacy and transformation spending. Therefore, our calculation of free cash flow will almost always result in a lower amount than cash from operating activities from continuing operations, the most directly comparable U.S. GAAP measure. However, the free cash flow measure is consistent with management's assessment of operating cash flow performance and we believe it provides a useful basis for investors and securities analysts about the cash generated by routine business operations, including capital expenditures, in addition to assessing our ability to repay debt, fund acquisitions and return capital to shareholders through share repurchases and dividends.
Our use of free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results under U.S. GAAP. First, free cash flow is not a substitute for cash provided (required) by operating activities of continuing operations, as it is not a measure of cash available for discretionary expenditures since we have non-discretionary obligations, primarily debt service, that are not deducted from the measure. Second, other companies may
51

calculate free cash flow or similarly titled Non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of free cash flow as a tool for comparison. Additionally, the utility of free cash flow is further limited as it does not reflect our future contractual commitments and does not represent the total increase or decrease in our cash balance for a given period. Because of these and other limitations, free cash flow should be considered along with cash provided (required) by operating activities of continuing operations and other comparable financial measures prepared and presented in accordance with U.S. GAAP.
The table below presents a reconciliation of free cash flow from the most directly comparable U.S. GAAP measure:
FREE CASH FLOW RECONCILIATION

(in Millions) | Nine Months Ended September 30,
2020 |  | 2019
Cash provided (required) by operating activities of continuing operations (GAAP) | $ | 313.5 |  |  | $ | 65.8 |
Transaction and integration costs (1) | 53.3 |  |  | 61.5 |
Adjusted cash from operations (2) | $ | 366.8 |  |  | $ | 127.3 |
Capital expenditures (3) | (35.2) |  |  | (56.8) |
Other investing activities (3)(4) | (23.1) |  |  | (20.7) |
Capital additions and other investing activities | $ | (58.3) |  |  | $ | (77.5) |
Cash provided (required) by operating activities of discontinued operations (5) | (66.3) |  |  | (36.2) |
Cash provided (required) by investing activities of discontinued operations (5) | 1.1 |  |  | 9.2 |
Transaction and integration costs (1) | (53.3) |  |  | (61.5) |
Investment in Enterprise Resource Planning system (3) | (42.2) |  |  | (42.0) |
Legacy and transformation (6) | $ | (160.7) |  |  | $ | (130.5) |
Free cash flow (Non-GAAP) | $ | 147.8 |  |  | $ | (80.7) |

___________________
(1) Represents payments for legal and professional fees associated with the DuPont Crop Protection Business Acquisition in addition to costs related to integrating the DuPont Crop Protection Business. See Note 5 to the condensed consolidated financial statements for more information.
(2) Adjusted cash from operations is defined as cash provided (required) by operating activities of continuing operations excluding the effects of transaction-related cash flows, which are included within Legacy and transformation.
(3) Components of cash provided (required) by investing activities of continuing operations. Refer to the below discussion for further details.
(4) Cash spending associated with contract manufacturers was $6.9 million and $4.1 million for the nine months ended September 30, 2020 and 2019, respectively.
(5) Refer to the above discussion for further details.
(6) Includes our legacy liabilities such as environmental remediation and other legal matters that are reported in discontinued operations as well as business integration costs associated with the DuPont Crop Protection Business Acquisition and the implementation of our new SAP system.
2020 Cash Flow Outlook
Our cash needs for 2020 include operating cash requirements (which are impacted by environmental, asset retirement obligation, and restructuring spending), capital expenditures, and legacy and transformation spending, as well as mandatory payments of debt, dividend payments, and share repurchases. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2020, our remaining borrowing capacity under our credit facility was $1,284.8 million.
We now expect our full year 2020 free cash flow (Non-GAAP) guidance range to be approximately $475 million to $525 million. For the nine months ended September 30, 2020, free cash flow increased approximately $230 million from the prior year period. Changes in other assets and liabilities, lower cash interest and taxes, lower capital investment, as well as growth in EBITDA above growth in trade working capital contributed to the year over year improvement. We continue to believe we can drive free cash conversion substantially higher over the next two to three years as we finalize our SAP system implementation, ending the three-year period of high cash spending on transformation activity and as we drive further improvement in working capital performance and continue to increase revenue and Adjusted EBITDA. While there is increased uncertainty in the global business environment, we are also taking several prudent steps to reduce cash outflows in 2020, such as deferring all discretionary capital investment and aggressively managing the balance of collections and payables to protect our cash position.
52

Although we provide a forecast for free cash flow, a Non-GAAP financial measure, we are not able to forecast the most directly comparable measure calculated and presented in accordance with U.S. GAAP, which is cash provided (required) by operating activities of continuing operations. Certain elements of the composition of the U.S. GAAP amount are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no U.S. GAAP outlook is provided.
Cash from operating activities of continuing operations
We expect higher cash from operating activities, excluding the effects of transaction-related cash flows, primarily driven by higher forecasted Adjusted EBITDA as well as continued improvement in working capital, to be in the range of approximately $750 million to $850 million. Transaction-related cash flows are included within Legacy and transformation, which is consistent with how we evaluate our business operations from a cash flow standpoint. See below for further discussion. Cash from operating activities includes cash requirements related to our pension plans, environmental sites, restructuring and asset retirement obligations, taxes, and interest on borrowings.
Pension
We do not expect to make any voluntary cash contributions to our U.S. qualified defined benefit pension plan in 2020. The plan is fully funded and our portfolio is comprised of 100 percent fixed income securities and cash. Our investment strategy is a liability hedging approach with an objective of maintaining the funded status of the plan such that the funded status volatility is minimized and the likelihood that we will be required to make significant contributions to the plan is limited.
Environmental
Projected 2020 spending, net of recoveries includes approximately $20 million to $30 million of net environmental remediation spending for our sites accounted for within continuing operations. Environmental obligations for continuing operations primarily represent obligations at shut down or abandoned facilities within businesses that do not meet the criteria for presentation as discontinued operations. This spending includes approximately $7 million related to our environmental remediation site near Pocatello, Idaho, primarily as a result of a litigation judgment against us in the Pocatello Tribal litigation. In addition to the expected 2020 payments for Pocatello, the judgment resulted in the requirement for future payments of $1.5 million annually thereafter. See Note 13 for further details on timing of payment of judgment due to United States Supreme Court review.
Total projected 2020 environmental spending, inclusive of sites accounted for within both continuing operations and discontinued sites (discussed within Legacy and transformation below), is expected to be in the range of $76 million to $86 million.
Restructuring and asset retirement obligations
We expect to make payments of approximately $15 million to $25 million in 2020, of which approximately $4 million is related to exit and disposal costs as a result of our decision to exit sales of all carbofuran formulations (including Furadan® insecticide/nematicide, as well as Curaterr® insecticide/nematicide and any other brands used with carbofuran products) in 2019.
Capital additions and other investing activities
Projected 2020 capital expenditures and expenditures related to contract manufacturers are expected to be in the range of approximately $100 million to $125 million. The spending is primarily driven by diamide capacity expansion and new active ingredient capacity. Expenditures related to contract manufacturers are included within "Other investing activities" on the condensed consolidated statement of cash flows.
Acquisitions
On October 2, 2020, we paid approximately $65 million to Isagro as part of the closing of the Fluidinapyr asset acquisition. In the fourth quarter 2020, this cash outflow will be reflected as acquisition spending within the investing section on the consolidated statement of cash flows. Consistent with our definition, acquisition related investing activities are not included in free cash flow.
53

Legacy and transformation
Projected 2020 legacy and transformation spending are expected to be in the range of approximately $175 million to $200 million. This is primarily driven by continued spending associated with the three-year implementation of a new SAP system and related costs. Except for the completion of certain in-flight initiatives, primarily associated with the finalization of our worldwide ERP system, we completed the integration of the DuPont Crop Protection Business as of June 30, 2020. As noted, the TSA is now terminated and the last phase of the ERP system transition went live in November 2020 with a stabilization period that will go into the first quarter of 2021. Total spending related to these initiatives is expected to be approximately $125 million. Costs for these initiatives are expected to be immaterial beyond 2020.
Projected 2020 spending, net of recoveries includes approximately $51 million to $61 million of net environmental remediation spending for our discontinued sites. These projections include spending as a result of a settlement reached in 2019 at our Middleport, New York site. The settlement will result in spending of approximately $20 million to $30 million per year for 2020 and 2021, due to front loading of reimbursement in installments of past costs, and a $10 million maximum per year thereafter, on average, until the remediation is complete.
Total projected 2020 environmental spending, inclusive of sites accounted for within both continuing operations (discussed within Cash from operating activities of continuing operations above) and discontinued sites, is expected to be in the range of $76 million to $86 million.
Share repurchases
During the nine months ended September 30, 2020, no shares were repurchased under the publicly announced repurchase program. At September 30, 2020, approximately $600 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We resumed share repurchases at the beginning of October and expect to continue to repurchase shares into December. We plan to repurchase $50 million in shares by the end of 2020 under our existing share repurchase authorization.
Dividends
During the nine months ended September 30, 2020 and September 30, 2019, we paid dividends of $171.3 million and $158.3 million, respectively. On October 15, 2020, we paid dividends totaling $57.2 million to our shareholders of record as of September 30, 2020. We expect to continue to make quarterly dividend payments. Future cash dividends, as always, will depend on a variety of factors, including earnings, capital requirements, financial condition, general economic conditions and other factors considered relevant by us and is subject to final determination by our Board of Directors.
Commitments and Contingencies
See Note 19 to the condensed consolidated financial statements included in this Form 10-Q.
Contractual Commitments
Information related to our contractual commitments at December 31, 2019 can be found in a table included within Part II, Item 7 of our 2019 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2020.
Climate Change
A detailed discussion related to climate change can be found in Part II, Item 7 of our 2019 Form 10-K.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Fair Value Measurements
See Note 18 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.
54

DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS
Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates, and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest, and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.
The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.
At September 30, 2020, our financial instrument position was a net asset of $10.3 million compared to a net liability of $8.9 million at December 31, 2019. The change in the net financial instrument position was primarily due to changes in foreign exchange and interest rates.
Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.
Commodity Price Risk
Energy costs are diversified among electricity and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and electricity. To analyze the effect of changing energy prices, we perform a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2020 and December 31, 2019, with all other variables (including interest rates) held constant. Note, as of September 30, 2020 and December 31, 2019, we had no open commodity contracts. As a result, there was no sensitivity analysis performed over commodity price risk for the periods presented.
Foreign Currency Exchange Rate Risk
The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the Euro, the Chinese yuan, the Brazilian real, Mexican peso, and the Argentine peso. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.
To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2020 and December 31, 2019, with all other variables (including interest rates) held constant.

(in Millions) | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets |  | 10% Strengthening |  | 10% Weakening
Net asset (liability) position at September 30, 2020 | $ | 13.7 |  |  | $ | 85.6 |  |  | $ | (61.8) |
Net asset (liability) position at December 31, 2019 | (8.0) |  |  | 55.9 |  |  | (75.4) |

Interest Rate Risk
One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2020, we had outstanding interest rate swap contracts in place with an aggregate notional value of $100.0 million.
To analyze the effects of changing interest rates, we have performed a sensitivity analysis in which we assume an instantaneous one percent change in the interest rates from their levels at September 30, 2020 and December 31, 2019, with all other variables held constant.

(in Millions) | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets |  | 1% Increase |  | 1% Decrease
Net asset (liability) position at September 30, 2020 | $ | (3.4) |  |  | $ | 6.0 |  |  | $ | (14.2) |
Net asset (liability) position at December 31, 2019 | (0.9) |  |  | — |  |  | (1.9) |

Our debt portfolio, at September 30, 2020, is composed of 73 percent fixed-rate debt and 27 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2017 Term Loan Facility,
55

commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.
Based on the variable-rate debt in our debt portfolio at September 30, 2020, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $6.6 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.5 million for the nine months ended September 30, 2020.
REGULATION FD DISCLOSURES
The Company’s investor relations website, located at https://investors.fmc.com, should be considered as a recognized channel of distribution, and the Company may periodically post important information to the web site for investors, including information that the Company may wish to disclose publicly for purposes of complying with the federal securities laws and our disclosure obligations under the SEC's Regulation FD. We encourage investors and others interested in the Company to monitor our investor relations website for material disclosures. Our website address is included in this Form 10-Q as a textual reference only and the information on the website is not incorporated by reference into this Form 10-Q.
56

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information required by this item is provided in "Derivative Financial Instruments and Market Risks," under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.
ITEM 4. CONTROLS AND PROCEDURES
(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2020, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Change in Internal Controls. There have been no changes in internal controls over financial reporting that occurred during the quarter ended September 30, 2020 that materially affected or are reasonably likely to materially affect our internal controls over financing reporting.
57

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
FMC Corporation:
Results of Review of Interim Financial Information
We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries (the Company) as of September 30, 2020, the related condensed consolidated statements of income (loss), comprehensive income (loss), and changes in equity for the three-month and nine-month periods ended September 30, 2020 and 2019, the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2020 and 2019, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2019, and the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
/s/ KPMG LLP
Philadelphia, Pennsylvania
November 3, 2020
58

PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Other matters. For additional discussion of developments in the legal proceedings disclosed in Part I, Item 3 of our 2019 Form 10-K, see Notes 13 and 19 to the condensed consolidated financial statements included within this Form 10-Q.
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A "Risk Factors" of our 2019 Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") for the fiscal year ended December 31, 2019, the risk factor in Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and the Company’s other filings with the SEC, which are available at www.sec.gov and on the Company’s website at www.fmc.com.
Forward-Looking Information
We wish to caution readers not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date made. We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
59

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
ISSUER PURCHASES OF EQUITY SECURITIES

|  |  |  |  |  | Publicly Announced Program
Period |  | Total Number of Shares Purchased (1) |  | Average Price Paid Per Share |  | Total Number of Shares Purchased |  | Total Dollar Amount Purchased |  | Maximum Dollar Value of Shares that May Yet be Purchased
July 2020 |  | 440 |  |  | $ | 107.55 |  |  | — |  |  | $ | — |  |  | $ | 600,000,620 |
August 2020 |  | 4,639 |  |  | 107.32 |  |  | — |  |  | — |  |  | 600,000,620 |
September 2020 |  | 343 |  |  | 110.30 |  |  | — |  |  | — |  |  | 600,000,620 |
Total Q3 2020 |  | 5,422 |  |  | $ | 107.53 |  |  | — |  |  | $ | — |  |  |

___________________
(1) Includes shares purchased in open market transactions by the independent trustee of the FMC Corporation Non-Qualified Savings and Investment Plan ("NQSP"). Purchase activity related to the NQSP is as follows: 440 shares at $107.55 per share during July; 34 shares at $108.54 per share during August and 34 shares at $107.45 per share during September.
During the nine months ended September 30, 2020, no shares were repurchased under the publicly announced repurchase program. At September 30, 2020, approximately $600 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans. In addition, the independent trustee of our non-qualified deferred compensation plan reacquires shares from time to time through open-market purchases relating to investments by employees in our common stock, one of the investment options available under the Plan.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS

15 |  | Awareness Letter of KPMG LLP
31.1 |  | Chief Executive Officer Certification
31.2 |  | Chief Financial Officer Certification
32.1 |  | CEO Certification of Quarterly Report
32.2 |  | CFO Certification of Quarterly Report
101 |  | Interactive Data File (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)

* Incorporated by reference
† Management contract or compensatory plan or arrangement
60

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| FMC CORPORATION (Registrant)
| By: | /s/ ANDREW D. SANDIFER
|  | Andrew D. Sandifer Executive Vice President and Chief Financial Officer

Date: November 3, 2020
61